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Patients  undergoing  high-­‐risk  surgeries  are  often  at  higher  risk  of  developing  
hemodynamic  instability  during  surgery  resulting  in  poor  postoperative  outcomes.  This  is  
usually  associated  with  significantly  increased  postoperative  morbidity  and  mortality,  which  
therefore  makes  the  early  identification  of  these  critical  events  and  those  patients  at  risk  of  
postoperative  complications  crucial.  With  these  motivations  in  mind,  we  first  created  a  large  
deidentified  research  dataset  of  surgical  case  medical  records  from  University  of  California,  
Irvine  Medical  Center  (UCIMC)  matched  with  physiological  waveforms  as  well  as  intermittent  
vital  sign  values,  lab  values,  and  ventilator  settings.  To  our  knowledge,  such  a  dataset  does  not  
currently  exist  for  the  intraoperative  environment.  We  hope  that  creating  a  such  a  dataset  will  
allow  for  advances  in  machine  learning  for  intraoperative  care.  Using  medical  data  from  UCLA,  
we  have  developed  deep  neural  network  models  to  classify  the  risks  of  postoperative  mortality,  
acute  kidney  injury,  and  reintubation  utilizing  readily  available  intraoperative  information.  Our  
 xiii 
risk  scores  were  compared  to  currently  commonly  used  risk  indices  ASA  and  Surgical  Apgar  as  
well  as  logistic  regression.  While  the  deep  neural  network  models  performed  better  than  the  
risk  scores  and  logistic  regression,  clinicians  require  additional  information  to  assess  what  led  to  
increased  risk  of  complications.  To  address  this,  we  also  assessed  the  use  of  generalized  
additive  neural  networks  (GANNs)  to  create  a  graphical  look  at  how  different  features  
contributed  to  the  risk  of  in  hospital  mortality.  Finally,  we  were  also  interested  in  predicting  
critical  intraoperative  events  to  allow  for  time  for  the  clinician  to  avoid  such  events.  We  focused  
on  intraoperative  hypotension  as  it  is  easier  to  define  and  has  been  shown  to  lead  to  increased  
risk  of  acute  kidney  injury,  stroke,  and  myocardial  injury.  For  the  hypotension  prediction  
models,  we  looked  at  the  arterial  pressure  waveform  and  EMR  data  as  inputs.    
Overall,  these  aims  address  a  gap  in  current  clinical  decision  guidance  and  support  to  























Patients  undergoing  high-­‐risk  surgeries  are  often  at  higher  risk  of  developing  
hemodynamic  instability  during  surgery  as  well  as  having  poor  postoperative  outcomes.  This  is  
usually  associated  with  significantly  increased  postoperative  morbidity  and  mortality,  which  
therefore  makes  the  early  identification  of  these  critical  events  and  those  patients  likely  to  have  
poor  outcomes  crucial.  As  instability  develops  in  a  patient,  there  are  small  but  complex  changes  
in  multiple  vital  signs  that  are  not  immediately  apparent  to  a  clinician.  This  instability  continues  
to  progress  until  significant  large  shifts  occur  in  the  patient  (i.e.  elevated  heart  rate  and  blood  
pressure),  which  are  now  obvious  and  detectable  by  the  clinician  but  at  which  point  may  be  too  
late  to  treat.  Known  methods  are  available  to  monitor  invasive  and  noninvasive  hemodynamic  
parameters  to  identify  instability,  however  no  such  mechanism  exists  to  predict  the  onset  of  
instability  in  real  time.    
Although  instability  can  be  identified  and  diagnosed  by  abnormalities  in  the  values  of  
hemodynamic  parameters  seen  on  clinical  monitors,  the  true  underlying  physiological  
mechanism  of  cardiorespiratory  instability  is  neither  straightforward  nor  linear  and  is  much  
more  complex.    Currently,  most  clinician  decisions  are  based  solely  on  the  values  of  individual  
hemodynamic  parameters  consistent  with  severe  instability  and  outside  of  normal  clinical  
range,  such  as  mean  arterial  blood  pressure  less  than  55  mmHg  or  a  heart  rate  greater  120  
bpm.  However,  the  definition  of  “normal”  is  subjective  to  the  treating  clinician.  While  there  are  
currently  available  risk  scores  such  as  the  Surgical  Apgar  score  and  real  time  parameters  such  as  
stroke  volume  variation  and  heart  rate  variability  that  are  used  to  better  guide  clinical  
decisions,  they  are  still  dependent  on  absolute  thresholds  of  normal  clinical  range.  It  is  known  
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that  there  is  large  patient  to  patient  variability,  and  to  focus  on  such  thresholds  is  a  major  
limitation.  While  there  is  the  goal  to  minimize  instability  during  surgery  to  improve  
postoperative  outcomes,  there  is  also  a  secondary  need  to  identify  patients  who  are  at  higher  
risk  for  postoperative  complications.  Being  able  to  identify  these  patients  would  allow  for  more  
effective  care  and  hopefully  avoid  complication  altogether.  In  addition,  with  the  payment  of  
healthcare  moving  towards  bundled  payments,  there  is  a  financial  need  to  efficiently  allocate  
hospital  resources  and  time.    
There  is  a  large  potential  for  significant  advancements  in  medicine  and  machine  learning  
methods  exist  to  help  utilize  the  underlying  complexity  of  patient  physiology  that  current  
clinical  monitors  and  decision  support  tools  lack.  We  hypothesize  that  deep  neural  networks  
can  leverage  the  complexity  of  intraoperative  data  taken  from  clinical  monitors  as  well  as  
medical  records  to  better  classify  risk  of  specific  postoperative  complications  and  better  predict  
postoperative  outcomes  as  well  as  the  onset  of  instability  (hypotension).    
With  more  than  230  million  major  surgical  procedures  are  performed  annually  
worldwide  and  an  estimated  10%  of  surgical  patients  at  high  risk  accounting  for  80%  of  
postoperative  deaths,  many  lives  can  be  saved  simply  by  identifying  patients  at  highest  risk  of  
specific  postoperative  complications  to  avoid  onset  of  those  complications.2–4  In  addition,  
helping  to  guide  the  intraoperative  anesthesia  care  can  help  reduce  this  risk  or  avoid  the  
complication  altogether.  Many  of  the  currently  developed  models  for  clinical  risk  are  not  robust  
to  patient  to  patient  variability  and  rely  on  limited  features  selected  by  domain  experts.  On  the  
other  hand,  while  there  is  work  being  done  utilizing  machine  learning,  including  deep  neural  
networks,  to  classify  patient  risk  and  leverage  time  series  data,  there  has  been  no  work  that  we  
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know  of  specific  to  the  intraoperative  environment  or  on  a  shorter  time  scale.  Events  in  the  
operating  room  are  on  the  order  of  minutes  or  even  seconds  to  an  adverse  event,  in  contrast  to  
the  slow  decline  of  patients  in  the  ICU  setting.  Much  of  the  advancement  of  model  
development  on  surgical  patients  has  also  been  limited  by  the  availability  of  data.  While  high  
resolution  clinical  data  exists  for  the  critical  care  setting  through  the  publicly  available  MIMIC  II  
database  created  by  the  Massachusetts  Institute  of  Technology,  the  same  such  database  does  
not  exist  for  the  surgical  setting.5  Thus,  the  creation  of  such  a  database  would  significantly  help  
to  advance  the  progress  of  research  on  these  types  of  patients.  
  
The  Need  for  Perioperative  Risk  Assessment  
It  has  been  shown  that  while  only  about  10%  of  surgical  patients  are  considered  at  high  
risk  for  complications,  this  high  risk  population  accounts  for  80%  of  postoperative  deaths.2–4  
Postoperative  complications,  as  defined  by  the  National  Surgical  Quality  Improvement  Program  
(NSQIP),  comprise  of  cardiac,  neural,  renal,  pulmonary,  and  vascular/thrombotic  events  as  well  
as  infections.  These  complications  include  cardiac  arrest,  renal  insufficiency  or  failure,  
pneumonia,  etc.  It  has  been  shown  that  occurrence  of  these  complications  within  30  days  
following  a  major  surgery  is  a  more  significant  determinant  of  survival  than  either  preoperative  
comorbidity  or  intraoperative  adverse  events.6  The  top  most  important  predictors  of  mortality  
included  the  following  postoperative  complications:  cardiac  arrest,  failure  to  wean,  systemic  
sepsis,  cerebrovascular  accident,  renal  failure,  myocardial  infarction,  and  renal  insufficiency.  
Therefore,  there  needs  to  be  a  focus  on  the  prevention  of  postoperative  complications.    
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One  such  method  of  avoiding  complications  would  be  direct  postoperative  critical  care  
admission.  Despite  the  high  mortality  rates  of  the  high  risk  surgical  population,  less  than  15%  of  
these  patients  are  admitted  to  the  ICU.2,3  This  suggests  a  systematic  failure  in  the  allocation  and  
process  of  critical  care  resources.  One  way  to  assist  with  this  would  be  able  to  identify  the  
patients  at  most  risk  of  major  postoperative  complications  and  death.  In  addition,  there  is  a  
need  for  identifying  patients  who  are  at  continued  risk  following  discharge.  Hospital  
readmission  within  30  days  is  broadly  considered  as  a  healthcare  quality  measure  and  cost  
driver  in  the  United  States,  and  under  the  Affordable  Care  Act,  Medicare  has  started  penalizing  
hospitals  according  to  their  30-­‐day  readmission  rate.  Currently,  about  1  in  5  Medicare  
beneficiaries  are  rehospitalized  within  30  days  after  discharge.7  Three  quarters  of  these  
readmissions  were  considered  avoidable.    In  2011,  there  were  approximately  3.3  million  adult  
30-­‐day  all-­‐cause  hospital  readmissions  in  the  United  States,  resulting  in  about  $41  billion  in  
hospital  costs  and  in  2004  Medicare  payments  for  unplanned  readmissions  accounted  for  
approximately  $17  billion.7,8  Overall,  there  is  a  need  for  methods  to  best  prioritize  care  to  avoid  
postoperative  complications  as  well  as  readmission  from  both  a  public  health  as  well  as  cost  
stand  point.  Such  methods  would  allow  for  hospital  systems  to  more  effectively  allocate  
resources  available  to  high  risk  patients.  
  
Current  Parameters  for  Risk  Assessment  
Accurate  risk  prediction  is  crucial  to  guiding  clinical  decision  and  management.  
Currently,  risk  assessment  is  performed  as  a  one-­‐time  risk  score  at  patient  admission  or  
presentation,  or  is  calculated  as  needed,  for  example  at  the  end  of  each  postoperative  day.  
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Some  well-­‐known  risk  scores  include  the  American  Society  of  Anesthesiologists  (ASA)  physical  
status  score,  Acute  Physiology  and  Chronic  Health  Evaluation  (APACHE)  II,  and  Surgical  Apgar.9–
11  The  ASA  score  was  developed  in  1963  and  is  still  used  in  the  preoperative  environment  as  a  
subjective  assessment  of  a  patient’s  overall  health  prior  to  surgery.  An  ASA  score  of  1  means  
completely  health  and  5  means  not  expected  live  24  hours.9  The  APACHE  score  is  calculated  
upon  admission  into  the  ICU  to  estimate  mortality,  and  takes  the  worst  values  of  vital  signs  such  
as  mean  arterial  pressure  and  heart  rate  as  well  as  labs  such  as  serum  creatinine  and  
hematocrit  from  the  first  24  hours  to  assign  risk  points.11  Out  of  a  possible  71  points,  the  higher  
the  score,  the  more  likelihood  of  mortality.  The  Surgical  Apgar  score,  also  a  point  based  system,  
uses  only  3  intraoperative  values:  estimated  blood  loss,  lowest  mean  arterial  pressure,  and  
lowest  heart  rate  to  predict  postoperative  risk  of  major  complication.10  There  are  also  risk  
scores  that  can  be  calculated  more  frequently  based  on  vital  signs.  These  types  of  scores  tend  
to  primarily  be  used  as  triggers  for  immediate  action  such  as  calling  the  rapid  response  teams  to  
recognize  and  respond  to  clinical  deterioration.  While  there  are  several,  two  well-­‐known  ones  
include  the  Modified  Early  Warning  Score  (MEWS)  and  the  Shock  Index.  MEWS  is  used  in  the  
critical  care  setting  and  is  calculated  at  intermittent  times  during  admission.12  MEWS  combines  
values  of  respiratory  rate,  heart  rate,  systolic  blood  pressure,  urine  output,  temperature  and  
neurological  assessment.  The  Shock  Index  is  mainly  used  in  critical  care  as  well  as  emergency  
settings.  It  is  calculated  as  the  ratio  of  heart  rate  over  systolic  blood  pressure  and  can  be  used  
to  predict  cardiac  arrest,  hypovolemic  shock,  and  sepsis.13  While  measures  like  MEWS  and  the  
Shock  Index  can  be  calculated  continuously  during  a  patient’s  admission,  they  are  currently  only  
calculated  on  a  “need  base”.  In  summary,  current  risk  scores  do  exist  for  patients  undergoing  
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surgery  and  critical  care.  However,  the  scores  themselves  as  well  as  the  clinical  variables  used  in  
their  calculations  tend  to  be  specific  to  the  preoperative  setting  or  are  calculated  once  the  
patient  is  already  in  critical  care.  In  response  to  this  there  has  been  work  to  create  newer  and  
potentially  more  robust  scores.    
  
Related  Work  in  Clinical  Risk  Modeling  Efforts  
The  above  scores  were  developed  to  create  a  set  of  easy  to  apply  rules  derived  from  
expert  opinion  on  what  leads  to  a  patient’s  deterioration.  With  the  passing  of  the  HITECH  Act  in  
2009,  there  has  been  an  explosion  in  the  amount  and  availability  of  electronic  medical  data.  
This  has  lead  to  a  growing  body  of  research  applying  predictive  models  to  medical  data.  The  
Preoperative  Score  to  Predict  Postoperative  Mortality  (POSPOM)  was  developed  as  a  
preoperative  risk  score  to  predict  postoperative  in  hospital  mortality.14  The  POSPOM  was  
developed  via  a  logistic  regression  model  that  takes  into  account  preoperatively  available  
patient  demographics  and  conditions  such  as  age,  diabetes  and  chronic  heart  failure  as  well  as  
type  of  surgery.  The  regression  coefficients  are  then  normalized  to  the  regression  coefficient  for  
age  to  create  POSPOM  points.  For  example,  age  has  a  regression  coefficient  of  0.303  and  
diabetes  and  chronic  heart  failure  have  regression  coefficients  of  0.189  and  1.124,  respectively,  
and  so  are  assigned  POSPOM  points  of  1  and  4,  respectively.  These  POSPOM  points  are  then  
summed  to  assign  the  patient  with  a  final  POSPOM.  In  addition,  there  is  the  Rothman  Index  (RI)  
which  claims  “real  time”  assessment  of  a  patient’s  current  condition,  and  was  developed  to  
predict  excess  risk  of  one  year  mortality,  which  was  defined  as  the  percent  increase  in  one  year  
all  cause  mortality  associated  with  each  clinical  variable  in  the  model.15  A  polynomial  regression  
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line  was  then  fit  to  the  data  to  create  an  “excess  risk  function”  for  each  clinical  variable.  The  
final  RI  is  essentially  the  sum  of  these  excess  risk  functions.  The  model  also  allows  for  
infrequently  collected  lab  test  values  via  creating  a  model  for  no  labs  and  a  model  with  labs.    
The  RI  score  is  calculated  every  time  a  new  model  input  is  available,  and  thus  is  in  “real  time”  
and  takes  26  clinical  variables,  including  lab  values.  RI  has  been  shown  to  be  correlated  with  
mortality  as  well  as  30  day  readmission.  While  RI  can  be  calculated  in  real  time,  it  is  still  limited  
by  the  time  lag  of  specific  variables  such  as  lab  values  and  nursing  assessments  that  are  
infrequent  and  irregular  and  the  prediction  is  not  actually  predicting  any  specific  in  hospital  
complications  or  in  hospital  mortality.    
There  is  also  work  being  done  on  more  specific  complications  such  as  reintubation  as  
well  as  acute  kidney  injury.  Acute  kidney  injury  develops  in  about  5%  of  hospitalized  patients.  
Acute  kidney  failure  has  been  shown  to  increase  cost,  length  of  stay,  as  well  as  mortality.  This  
highlights  the  need  for  accurate  prediction  of  AKI  for  early  diagnosis  and  treatment.  There  have  
been  risk  scores  developed  to  predict  acute  kidney  injury  following  surgery  such  as  one  
developed  by  Thakar  et  al.16  Similar  to  the  POSPOM,  Thakar’s  AKI  risk  score  used  logistic  
regression  model  to  select  the  most  significant  features  and  those  features  are  assigned  points  
based  on  the  the  regression  coefficients.    Score  points  were  calculated  as  the  regression  
coefficient  multiplied  by  2  and  rounded  to  the  nearest  integer.  The  final  AKI  risk  score  is  a  sum  
of  these  points.  This  model,  like  POSPOM,  also  uses  only  preoperatively  available  information  
such  as  comorbidities  like  COPD  and  diabetes,  as  well  as  surgery  type  and  preoperative  
creatinine.  However,  it  was  specifically  developed  on  and  for  cardiac  patients.  Another  AKI  
score,  but  one  for  non-­‐cardiac  surgery  patients,  was  developed  also  using  only  preoperative  
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patient  information.17,18  Following  development  of  a  logistic  regression  model,  risk  scores  were  
assigned  similar  to  POSPOM  and  Thakar  et  al.  with  the  regression  coefficient  normalized  to  the  
smallest  coefficient  then  multiplied  by  2  and  rounded.  This  study  also  assessed  intraoperative  
hypotension  as  a  potential  variable  for  the  risk  of  AKI.  Intraoperative  hypotension  features  
included  amount  of  time  blood  pressure  was  less  than  an  absolute  hypotension  cutoff  such  as  
SBP  <  80  mmHg,  SBP  <  70,  as  well  as  intraoperative  vasopressor  administration  and  urine  
output.  No  specific  amount  or  duration  of  hypotension  was  found  to  be  associated  with  AKI  in  
this  study,  however  in  other  studies  intraoperative  hypotension  has  been  shown  to  highly  
correlate  with  post  operative  complications  such  as  cardiac  death,  pulmonary  edema,  mortality,  
and  excess  length  of  stay.19–24  This  highlights  the  potential  for  using  prevention  of  hypotension  
as  a  continuous,  intraoperative  way  to  change  decision  and  management  to  improve  
postoperative  outcomes.    
Apart  from  AKI,  other  postoperative  complications  of  concern  are  respiratory  ones  such  
as  pneumonia,  failure  to  wean,  and  post  extubation  respiratory  failure,  which  have  been  shown  
to  be  the  second  most  frequent  type  of  postoperative  complication  after  wound  infection.6,24,25    
Post  extubation  respiratory  failure  has  been  shown  to  increase  poor  outcomes  and  mortality.6  
Thus,  being  able  to  predict  which  patients  are  at  highest  risk  of  post  extubation  respiratory  
failure  is  clinically  important.  A  preoperative  risk  score  to  predict  risk  of  postoperative  
reintubation  has  been  developed  combining  only  5  features  (ASA>3,  emergency  procedure,  
high  risk  service,  congestive  heart  failure,  and  chronic  pulmonary  disease).26  Similar  to  other  
models,  the  Score  for  Prediction  of  Postoperative  Respiratory  Complications  (SPORC)  also  uses  
a  logistic  regression  model’s  coefficients  to  assign  points  to  each  feature  which  are  then  
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summed  as  the  final  risk  score.  In  addition  to  the  current  work  in  complications  risk,  there  have  
also  been  efforts  to  predict  risk  of  readmission  in  specific  cohorts  of  patients  such  as  congestive  
heart  failure,  cancer,  and  emergency.27,28  The  Preadmission  Readmission  Detection  Model  
(PREADM)  was  developed  as  a  logistic  regression  model  to  predict  30  day  readmission  using  11  
variables  that  included  chronic  conditions,  prior  health  services  uses,  BMI,  and  geographical  
location  (PREADM).  Again,  similarly  to  other  models  discussed  here,  the  regression  coefficients  
were  transformed  into  scoring  points.    
There  is  also  current  research  in  utilizing  other  methods  apart  from  logistic  regression.  
One  study  compared  using  support  vector  machines,  logistic  regression,  decision  trees,  random  
forest  and  generalized  boosted  modeling  for  predicting  both  hospital  readmission  as  well  as  
cost  of  that  readmission,  and  found  that  all  methods’  results  were  comparable.29  Variables  used  
in  that  study  were  mainly  patient  demographic  and  admission  information  such  as  age,  
ethnicity,  admission  type,  number  of  co  morbidities,  length  of  stay,  with  the  only  vital  sign  
being  blood  pressure  at  discharge.  Another  study  utilized  random  forests  to  forecast  
cardiorespiratory  instability,  using  continuous  and  high  resolution  vital  signs  such  as  heart  rate,  
respiratory  rate,  and  blood  pressure.30  Deep  neural  networks,  or  deep  learning,  is  also  
becoming  a  popular  approach.  One  study  utilized  temporal  convolutional  neural  networks  on  
lab  values  to  predict  onset  of  diseases  such  as  atrial  fibrillation  and  chronic  kidney  disease.31  
Another  applied  LSTM  recurrent  neural  networks  to  predict  mortality  and  number  of  ventilator  
free  days.32  They  used  static  features  such  as  demographics  and  admission  diagnosis  as  well  as  
temporal  features  such  as  ventilator  settings  and  blood  gas  values).    Nguyen  et  al.  developed  
Deepr  (Deep  net  for  medical  Record),  a  convolutional  neural  network  that  takes  the  electronic  
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clinical  notes  from  patient  visits  to  predict  future  outcomes  (specifically  diagnoses  and  
procedures).33    Lipton  et  al.  utilized  LSTM  recurrent  neural  networks  to  recognize  patterns  in  
multivariate  time  series  of  clinical  measurements  (vital  signs  as  well  as  labs)  to  classify  
diagnoses.34    
The  ultimate  goal  of  all  the  above  current  research  is  to  change  modern  medicine  to  
becoming  more  prospective  or  proactive,  rather  than  reactive.  There  are  2  ways  to  think  of  
prospective  healthcare:  1)  A  one-­‐time  risk  classification  to  help  allocate  hospital  resources  
more  efficiently  to  ensure  patients  receive  necessary  critical  care  and  2)  Continuous,  real  time  
risk  classification  to  avoid  onset  of  complications  altogether.  One-­‐time  risk  classification  would  
be  to  better  predict  which  patients  are  at  risk  of  which  bad  outcomes  or  complications.  This  
would  be  to  help  stratify  patients  prior  to  care  and  better  allocate  hospital  time  and  resources.  
Continuous  risk  classification  would  be  similar  to  a  new  continuous  vital  sign  for  a  patient,  i.e.  
an  arterial  blood  pressure  signal  that  outputs  blood  pressure  values  every  20  seconds.  The  
point  of  a  continuous  risk  indicator  would  be  to  predict  short  term  onset  of  adverse  events  such  
as  atrial  fibrillation.  We  believe  that  the  best  way  to  do  both  is  through  deep  learning.  
  
Introduction  to  Deep  Neural  Networks  
Deep  neural  networks,  aka  deep  learning,  is  a  currently  popular  approach  in  machine  
learning.  The  aim  of  deep  learning  is  to  learn  from  raw  data  and  perform  desired  tasks  without  
any  feature  engineering.  In  other  words,  deep  learning  is  capable  of  modeling  the  complex  
nonlinear  and  linear  features  from  low  level  features  or  raw  data  that  are  necessary  for  an  
accurate  output.  Current  deep  learning  is  mostly  based  on  multilayered  neural  networks,  where  
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each  layer  is  connected  via  neurons.35  Each  neuron  applies  a  nonlinear  transform  to  a  linear  
function  of  inputs.  This  is  referred  to  as  an  activation  function  and  the  most  commonly  used  
ones  are  sigmoid,  tanh,  and  the  Rectified  Linear  Unit  (ReLU).  The  sigmoid  function  𝜎(𝑥) =	   ''()*+    has  a  range  of  0  to  1.  The  tanh  nonlinearity  has  a  range  of  -­‐1  to  1  and  can  be  considered  
a  scaled  sigmoid  neuron  where  tanh(𝑥) = 	  2𝜎(2𝑥) − 	  1.  ReLU  simply  thresholds  a  value  at  zero  
via  the  function  𝑓(𝑥) = 	  max	  (0, 𝑥).    Deep  learning  has  been  developed  for  decades,  but  over  
the  past  few  years  it  has  broken  records  in  visual  object  recognition,  speech  recognition,  and  
natural  language.36  There  are  three  main  types  of  deep  neural  networks:  feedforward,  
recurrent,  and  convolutional.  Feedforward  networks  pass  information  from  one  end  to  the  
other,  usually  input  to  output,  and  can  be  thought  of  as  universal  function  approximators.37  
Recurrent  neural  nets  (RNNs)  model  varying  length  sequential  data  (sequential  over  time  or  
space)  and  can  maintain  some  form  of  memory  and  capture  long  term  dependencies.38  RNNs  
selectively  pass  information  across  sequential  steps,  while  processing  sequential  data  one  
element  at  a  time.  Convolutional  neural  nets  (CNNs)  exploit  local  motifs  across  time  and  space,  
small  pieces  of  data  with  predefined  sizes  such  as  a  batch  of  pixels.  CNNs  contain  convolutional  
layers  that  aim  to  learn  feature  representations  of  the  inputs  and  compute  different  feature  
maps.39    
UCI  ANESTESHIOLOGY  RESEARCH  DATABASE  
All  data  collected  in  this  study  was  obtained  with  IRB  approval  from  UC  Irvine,  and  was  a  
collaborative  effort  with  Edwards  Lifesciences  (Irvine,  CA),  CardioPulmonary  
Corporation/Bernoulli  (Milford,  CT)  and  the  Department  of  Anesthesiology  at  UC  Irvine  Medical  
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Center  (UCIMC).  All  data  in  this  effort  were  deidentified  prior  to  access  by  IRB  approved  
researchers.  
  
Creating  the  Database  
Starting  in  August  of  2015,  all  adult  surgical  patients  presenting  at  all  nineteen  UCI  
operating  suites  have  been  being  consented  for  data  collection.  This  database  consists  of  three  
types  of  clinical  data:  high  resolution  waveforms,  intermittent  values,  and  clinical  anesthesia  
record.  We  are  currently  collecting  three  types  of  high  resolution  waveforms:  arterial  blood  
pressure,  EKG,  and  plethysmography  directly  from  the  GE  (General  Electric  Healthcare,  Chicago,  
IL)  patient  monitors  (B850  and  Solar  8000)  in  the  operating  room  (OR).  Intermittent  values  are  
collected  as  standard  of  care  and  are  contained  in  the  anesthesia  medical  record.  Intermittent  
values  consist  of  the  standard  vital  signs  such  as  heart  rate  and  blood  pressure,  but  also  include  
ventilator  values  such  as  end  tidal  CO2  and  PEEP.  Intermittent  values  also  consist  of  any  
manually  input  lab  values  such  as  hemoglobin.  The  anesthesia  record  also  consists  of  all  
medical  record  data  associated  with  the  surgical  case,  including  patient  demographics  as  well  as  
drug  and  fluid  interventions.  Combining  all  three  types  of  clinical  data  makes  this  database  
unique  and  novel.  Data  collection  currently  remains  ongoing  with  IRB  renewal.  
  
Contents  of  the  Database  
The  data  available  in  the  UCI  database  was  collected  from  two  sources:  the  
intraoperative  electronic  medical  record  (EMR)  and  directly  from  the  GE  bedside  monitor  
(Figure  1).    All  EMR  data  was  pulled  retrospectively  once  a  week  by  the  UC  Irvine  Medical  
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Center  (UCIMC)  Honest  Broker  and  pushed  to  a  data  processing  server.  All  waveforms  were  
collected  by  Bernoulli  systems  from  bedside  monitors  and  pushed  to  the  data  processing  server  
before  being  aggregated  with  EMR  data,  post  processed,  and  deidentified.  These  data  can  be  
separated  into  specific  classes  summarized  in  Table  1.      
  
Figure  1.  Overview  of  data  collection  points  
 
Table  1.  Description  of  data  classes  and  sources  found  in  the  UCIMC  Anesthesiology  Research  Database  
Data  Class   Source   Description  
Descriptive   EMR   Demographic  detail,  ASA  score,  admission  type,  surgical  description  
Events   EMR   All  manually  annotated  intraoperative  events  (e.g.  induction,  intubation)  and  physician  comments  
Adverse  Events   EMR   All  manually  annotated  intraoperative  adverse  events  or  complications  
Medications   EMR   All  manually  annotated  administered  medications  and  fluids  
Manual  
Observations   EMR  
All  manually  input  observations  including  
intraoperative  blood  gas  values,  estimated  blood  
loss,  and  urine  output  
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Automated  
Observations   EMR  
All  automatically  collected  1  minute  observations  
such  as  intermittent  vital  signs  (e.g.  heart  rate,  
blood  pressure),  ventilator  settings  (e.g.  tidal  





All  automatically  collected,  available  waveforms  
(EKG,  Plethysmographic,  Arterial  Blood  Pressure)  
  
Electronic  Medical  Record  (EMR)  Data  
All  EMR  data  was  obtained  from  the  intraoperative  EMR  system  Surgical  Information  
Systems  (SIS)  and  pushed  to  the  data  server  by  a  UCIMC  once  per  week.  All  data  was  organized  
to  replicate  the  SIS  EMR  structure  of  6  unique  EMR  classes,  which  were  saved  as  individual  csv  
files  per  patient  (Table  2).  
Table  2.  Description  of  the  6  EMR  classes  of  data  pulled  from  the  UCIMC  Surgical  Information  Systems  
(SIS)  per  patient.  
EMR  Type   Description  
Patient  
•   Free  text  surgery  description  
•   Admission  type  
•   Height,  weight,  age,  sex  
•   American  Society  of  Anesthesia  (ASA)  Score  
•   Surgery  and  anesthesia  start  and  stop  times    
Category   •   Adverse  events  that  occurred  intraoperatively  
Events  
•   Comments  by  the  anesthesiologist  during  surgery  
•   All  standard  anesthesia  events  such  as  intubation,  
induction,  arterial  line  placement,  positional  changes  etc.  
with  timestamps    
Drugs  and  
Fluids  
•   All  start  and  end  (if  available)  timestamps  annotated  by  
the  clinician  
•   Medication  name  
•   Volume  administered  or  rate  of  administration    
Input/Output  
•   All  Estimated  Blood  Loss  and  Urine  Output  values  
annotated  by  the  clinician  with  time  stamps  
•   Total  sum  of  volumes  of  fluids  administered    
Observations  
•   All  1  minute  sampled  vitals  and  ventilator  information  
with  timestamps  
•   All  manually  input  vitals  with  timestamps  
•   All  manually  input  lab  values  with  timestamps    
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Physiologic  Waveform  Data  
All  physiologic  waveform  data  was  collected  from  the  bedside  monitors  using  Bernoulli  
systems.  Every  operating  room  (OR)  of  UCIMC  currently  contains  one  of  the  following  bedside  
monitors:  GE  Solar  8000  or  GE  B850.  The  Bernoulli  system  acquires  a  maximum  of  2  (GE  Solar  
8000)  or  3  (GE  B850)  waveform  channels  directly  from  the  monitors,  and  all  waveform  data  per  
OR  was  saved  into  XML  files.  The  newer  GE  B850  monitors  output  all  3  waveform  channels:  EKG  
sampled  at  300  Hz,  plethysmograph  sampled  at  100  Hz,  and  invasive  arterial  blood  pressure  (if  
available)  sampled  at  100  Hz.  The  older  GE  Solar  8000  monitors  have  an  analog  output  and  
output  only  2  waveform  channels:  EKG  and  invasive  arterial  blood  pressure  (if  available).  It  
should  be  noted  that  due  to  the  analog  output  of  the  GE  Solar  monitors,  the  sampling  rate  was  
approximated  in  post-­‐processing  for  corrected  time  alignment  with  EMR  data.  All  waveform  
data  from  each  OR  were  transmitted  through  the  hospital  network  to  a  data  processing  server,  
where  it  was  temporarily  stored  until  the  EMR  data  was  available  on  the  data  server  for  data  
processing  as  described  in  Figure  1.  
  
EMR  and  Waveform  Data  Postprocessing  
The  surgery  start  and  stop  times  and  OR  location  from  the  EMR  data  were  used  to  parse  
and  match  waveform  data  to  the  correct  patient.  In  the  EMR  data,  unique  surgeries  are  
identified  by  a  unique  Case  Confirmation  Number  (CCN).  The  CCN  is  unique  to  the  surgical  case,  
while  a  medical  record  number  is  unique  to  the  patient,  i.e.  a  patient  can  have  only  1  MRN  but  
multiple  CCNs.  We  chose  to  keep  each  surgical  case  unique  and  used  the  CCN  to  identify  
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patients  and  their  associated  data.  Once  the  waveforms  and  EMR  data  were  matched  and  
aggregated,  all  data  was  assigned  a  new  unique  deidentified  ID.  
The  waveform  data  is  parsed  into  30  minute  XML  files  per  patient.  To  be  more  user-­‐
friendly,  the  waveform  data  was  processed  in  a  secondary  step.  First,  all  the  waveform  data  
was  translated  from  16  bit  data.  Due  to  hardware  and  monitor  limitations,  there  also  exists  
data  gaps.  In  the  GE  B850,  these  are  annotated  as  flags  by  the  monitor  itself.  However,  in  the  
GE  Solar  8000,  the  data  gaps  are  identified  via  an  algorithm  and  assumed  to  be  true.  After  the  
waveforms  are  corrected  for  data  gaps  they  are  also  corrected  for  gain  and  sampling  
frequencies  to  be  time  synced  with  the  EMR  data.  Waveform  data  are  saved  in  a  .bin  file  format  
that  includes  patient  sex,  age,  height,  weight,  Body  Surface  Area  (BSA),  sampling  frequency,  and  
start  timestamp  (in  serial  format).  
Deidentification  and  HIPPA  Compliance  
All  patient  identifiers  such  as  name,  medical  record  number  (MRN)  and  social  security  
number  (SSN)  were  completely  removed  and  all  birthdates  were  replaced  with  age  at  the  date  
of  surgery  prior  to  being  made  available  to  IRB-­‐approved  researchers.  Before  making  a  
database  to  be  accessible  by  a  larger  group  of  researchers,  we  intend  to  do  further  
deidentification  of  the  data.  This  includes  the  removal  and  replacement  of  all  timestamps  with  





The  first  version  of  the  UCI  database  includes  data  from  all  distinct  surgeries  from  UC  
Irvine  Medical  Center  (UCIMC)  performed  between  2015  and  2017.  In  2017,  UCIMC  
transitioned  from  Surgical  Information  Systems  to  Epic  (Verona,  WI)  for  their  intraoperative  
EMR.  Additional  data  collection  is  ongoing,  however  not  merged  or  processed.  Table  3  provides  
a  summary  of  the  patient  population.  
Table  3.  Summary  of  patient  population  in  UCIMC  Research  Database  2015  –  2017.  Data  is  represented  
in  mean  ±  standard  deviation,  unless  otherwise  noted.  
#  of  OR  Days   630  
  
#  of  Patients   19,636  
  
ASA   #  Patients   %  of  Patients  
1   561   2.86  
1E   78   0.40  
2   6,175   31.45  
2E   288   1.47  
3   9,455   48.15  
3E   446   2.27  
4   2,039   10.38  
4E   386   1.97  
5   20   0.10  
5E   155   0.79  
6   27   0.14  
6E   6   0.03  
Age  (years)   52  ±  19  
  
Gender   #  Patients   %  of  Patients  
Female   9,985   50.85  
Male   9,645   49.12  
Other   2   0.01  
Unknown   4   0.02  
Admission  Type   #  Patients   %  of  Patients  
Inpatient   7,630   38.86  
23  Hour  Observation   2,165   11.03  
AM  Admission   4,491   22.87  
Outpatient   5,189   26.43  
Midnight  Admission   58   0.30  
Day  Prior  Admission   93   0.47  
Unknown   10   0.05  
Anesthesia  Type   #  Patients   %  of  Patients  
General   17,629   89.78  
MAC   1,693   8.62  
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Regional  Block   104   0.53  
Spinal   139   0.71  
Combined  Spinal/Epidural   17   0.09  
Combined  
General/Epidural  
10   0.05  
Epidural   11   0.06  
Local   4   0.02  
Bier  block   9   0.05  
None   18   0.09  
Unknown   2   0.01  
Total  Anesthesia  Time   3  hours  20  minutes  ±  2  hours  13  minutes  
  
  
Data  Mining  Tools  
  
The  goal  of  this  data  effort  is  to  promote  research.  To  make  the  UCI  database  more  user  
friendly,  we  have  created  definition  tables  for  the  EMR  classes  Events,  Observations,  and  Drugs  
(Table  4,  5,  6,  respectively),  as  well  as  various  data  mining  resources.  The  definition  tables  
contain  all  the  unique  possible  item  names  found  in  each  EMR  class,  with  metadata  in  the  form  
of  number  of  times  the  item  is  present  as  well  as  number  of  unique  patients  with  the  item  
name.  For  the  Observations  class,  we  included  a  long  label  provided  by  UCIMC  SIS  as  well  as  
manually  assigned  description  of  the  item  name  (Table  5).    For  the  Drugs  class,  we  included  the  
manually  assigned  common  drug  types  (i.e.  analgesic,  vasopressor,  vasodilator,  etc.)  as  well  as  
the  unique  units  found  for  the  specific  item  name  (Table  6).  We  have  also  created  data  mining  
resources  for  querying  the  database  based  on  these  definition  tables  as  well  as  visualization  







Table  4.  Sample  subset  of  definition  table  for  EMR  Events.  
  
Event  Name   Event  Counts   Patient  Counts  
MD  Maintenance   16130   7038  
Anesthesia  Positioning  Note   10942   7754  
Rhythm   10286   7829  
Anesthesia  Note   9624   4115  
SBar  Time   8190   7851  
Report  to  RN   8050   7891  
Temperature  Management   8046   7752  
Patient  Positioning   7938   7887  
Anesthesia  Time   7891   7891  
Surgery  Time   7891   7891  
Time  out  completed   7891   7891  
Patient  Transport  Note   7890   7890  
Pre-­‐Induction  Patient  Safety   7886   7886  
OR  Time   7861   7861  
  
Table  5.  Sample  subset  of  definition  table  for  EMR  Observations.  
Observation  
Name   Long  Label   Description  
Observation  
Counts   Patient  Counts  




1398284   7854  
















295431   7847  





Respiratory  rate   1120342   7837  
T1      Temperature   887261   7835  
ETCO2  
End  Tidal  Carbon  
Dioxide  Amount  -­‐  
Capnometer  
Wave  
End  tidal  carbon  
dioxide  
concentration  
1422340   7790  
FiO2   Gas  Monitor  DC3424  
Inspired  oxygen  
concentration   1420074   7788  
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Table  6.  Sample  subset  of  definition  table  for  EMR  Drugs.  
Drug  Name   Drug  Category   Drug  Counts   Unique  Units   Patient  Counts  
FENTANYL   analgesic  -­‐  narcotic   23565   'MICROgm,  ML'   7274  
PROPOFOL   anesthetic   13642   'MICROgm,  mg'   6775  
MIDAZOLAM   benzodiazepine   6451   'mcg,  mg'   5862  
ONDANSETRON   antiemetic   5582   'mg'   5381  
LIDOCAINE   analgesic  -­‐  local   4855   'mL,  mg,  ml'   4755  
GLYCOPYRROLATE   anticholinergic   4446   'mg'   3771  
PLASMALYTE   crystalloid   8655   'mL'   3713  
PLASMALYTE   crystalloid   8655   'mL'   3713  
DEXAMETHASONE   glucocorticoid   3760   'MG,  mg'   3674  





3474   'mg'   3402  
PHENYLEPHRINE   vasopressor   12251   'MICROgm,  Mcg,  mg'   3114  
EPHEDRINE   vasopressor   7723   'mg'   3042  
SUCCINYLCHOLINE   paralytic   2881   'mg'   2832  
LACTATED  RINGERS   crystalloid   4926   'mL'   2819  
  
  
Figure  2.  Example  of  a  UCI  surgical  patient's  arterial  blood  pressure  waveform  plotted  with  noninvasive  
blood  pressure  cuff  (MAP  cuff)  and  invasive  arterial  blood  pressure  (MAP  Aline)  measurements  from  the  




PREDICTING  POSTOPERATIVE  IN-­‐HOSPITAL  MORTALITY  
  
About  230  million  surgeries  are  performed  annually  worldwide.40  While  the  estimated  
postoperative  mortality  is  low,  less  than  2%,  studies  have  shown  that  about  12%  of  all  patients  -­‐  
the  high-­‐risk  surgery  group  -­‐  account  for  80%  of  postoperative  deaths.  To  assist  in  guiding  
clinical  decisions  and  prioritization  of  care,  several  perioperative  clinical  and  administrative  risk  
scores  have  been  proposed.  These  scores  tend  to  be  subjective  like  the  American  Society  of  
Anesthesiologists  (ASA)  physical  status  score  (a  preoperative  score)  or  are  developed  using  
simple  methods  like  logistic  regression,  such  as  with  the  Preoperative  Score  to  Predict  
Postoperative  Mortality  (POSPOM).9,14    
In  collaboration  with  UCLA  Medical  Center’s  Department  of  Anesthesiology,  our  first  
deep  neural  network  (DNN)  models  were  created  for  predicting  in  hospital  mortality.  
Performance  is  presented  together  with  other  published  clinical  risk  scores  (ASA,  Surgical  
Apgar,  POSPOM)  and  administrative  risk  scores  (Risk  Stratification  Index  and  Risk  Quantification  
Index),  as  well  as  a  logistic  regression  model  using  the  same  intraoperative  features  as  the  
DNN.9,10,14,41–43  The  DNNs  were  also  assessed  for  leveraging  preoperative  information  by  the  
addition  of  ASA  and  POSPOM  as  features.  This  work  has  been  published.44  
  
Data  Description  
Electronic  Medical  Record  (EMR)  Data  Extraction     
All  data  for  this  study  were  extracted  from  the  Perioperative  Data  Warehouse  (PDW),  a  
custom  built  robust  data  warehouse  containing  all  patients  who  have  undergone  surgery  at  
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UCLA  since  the  implementation  of  the  electronic  medical  record  (EMR)  (EPIC  Systems,  Madison  
WI)  on  March  17th,  2013.  The  construction  of  the  PDW  has  been  previously  described.45All  data  
used  for  this  study  were  obtained  from  this  data  warehouse  and  IRB  approval  was  been  
obtained  for  this  retrospective  review.    
A  list  of  all  surgical  cases  performed  between  March  17,  2013  and  July  16,  2016  were  
extracted  from  the  PDW.  The  UCLA  Health  System  includes  two  inpatient  medical  centers  as  
well  as  three  ambulatory  surgical  centers,  however  only  cases  performed  in  one  of  the  two-­‐
inpatient  hospitals  (including  operating  room  and  “off-­‐site”  locations)  under  general  anesthesia  
were  included  in  this  analysis.  Cases  on  patients  younger  than  18  years  of  age  or  older  than  89  
years  of  age  were  excluded.  In  the  event  that  more  than  one  procedure  was  performed  during  
a  given  health  system  encounter  only  the  first  case  was  included.  
Model  Endpoint  Definition  
The  occurrence  of  an  in-­‐hospital  mortality  was  extracted  as  a  binary  event  [0,  1]  based  
upon  either  the  presence  of  a  “mortality  date”  in  the  EMR  between  surgery  time  and  discharge  
or  a  discharge  disposition  of  expired  combined  with  a  note  associated  with  the  death  (i.e.  death  
summary,  death  note).  The  definition  of  in-­‐hospital  mortality  was  independent  of  length  of  stay  
in  the  hospital.  
Model  Input  Features  
Each  surgical  record  corresponded  to  a  unique  hospital  admission  and  contained  87  
features  calculated  or  extracted  at  the  end  of  surgery  (Table  7).  These  features  were  considered  
to  be  potentially  predictive  of  in-­‐hospital  mortality  by  clinicians’  consensus  and  included  
descriptive  intraoperative  vital  signs,  such  as  minimum  and  maximum  blood  pressure  values;  
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summary  of  drugs  and  fluids  interventions  such  as  total  blood  infused  and  total  vasopressin  
administered;  as  well  as  patient  anesthesia  descriptions  such  as  presence  of  an  arterial  line  and  
type  of  anesthesia  (all  features  are  detailed  in  Table  7).    
Table  7.  Description  of  model  input  features  and  applied  maximum  possible  values  as  defined  by  domain  
experts.  






COLLOID_ML*     Total  Colloid  Transfused  (ml)   -­‐  
CRYSTALLOID_ML*   Total  Crystalloid  Transfused  (ml)   -­‐  
DBP  MAX*,  MIN*,  AVG,  
MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Diastolic  Blood  Pressure  for  the  
case  (mmHg)    
150  
DBP_10min  MAX,  MIN,  
AVG,  MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Diastolic  Blood  Pressure  for  the  
last  10  minutes  of  the  case  (mmHg)  
150  
EBL*   Total  Estimated  Blood  Loss  (ml)   -­‐  
EPHEDRINE  BOLUS*   Total  bolus  dose  of  Ephedrine  (mg)  during  the  case   -­‐  
EPINEPHRINE  BOLUS*,  
END  RATE*,  MAX  RATE*  
Total  bolus  dose  (mcg),  End  of  case  infusion  rate  
(mcg/kg/min),  and  Highest  infusion  rate  
(mcg/kg/min)  of  Epinephrine  during  the  case  
-­‐  
ESMOLOL  BOLUS*,  END  
RATE*,  MAX  RATE*  
Total  bolus  dose  (mg),  End  of  case  infusion  rate  
(mcg/kg/min),  and  Highest  Infusion  rate  
(mcg/kg/min)  of  Esmolol  during  the  case  
-­‐  
HR  MAX*,  MIN*,  AVG,  
MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Heart  Rate  (bpm)  for  the  case   180  
HR_10min  MAX,  MIN,  
AVG,  MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Heart  Rate  (bpm)  for  the  last  10  
minutes  of  the  case  
180  
INVASIVE_LINE_YN*   Invasive  Central  venous,  arterial,  or  Pulmonary  Arterial  Line  used  for  the  case  (Yes/No)   -­‐  
MAP  MAX*,  MIN*,  AVG,  
MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Mean  Blood  Pressure  (mmHg)  
for  the  case  
300  
MAP_10min  MAX,  MIN,  
AVG,  MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Mean  Blood  Pressure  (mmHg)  




Maximum  Minimum  alveolar  concentration  of  
desflurane  during  the  case  (note  this  is  not  age  
adjusted)  
12  
GLUCOSE  MAX*,  MIN*   Maximum  and  Minimum  plasma  Glucose  concentration  for  the  Case  (mg/dl)   400  
ISO  MAX*  
Maximum  Minimum  alveolar  concentration  of  




Maximum  Minimum  alveolar  concentration  of  
sevoflurane  during  the  case  (note  this  is  not  age  
adjusted)  
10  
MILRINONE  END  RATE*,  
MAX  RATE*  
End  of  case  Infusion  Rate  and  Highest  Infusion  rate  
of  Milrinone  during  the  case  (mcg/kg/min)   -­‐  
HGB  MIN*   Minimum  Hemoglobin  concentration  (g/dl)  during  the  case   15  
MINUTES  MAP  <  50   Cumulative  minutes  with  mean  arterial  pressure  <50  mmHg  (min)   -­‐  
MINUTES  MAP  <  60   Cumulative  minutes  with  mean  arterial  pressure  <  60  mmHg  (min)   -­‐  
NICARDIPINE  END  RATE*,  
MAX  RATE*  
End  of  case  infusion  Rate  and  Highest  Infusion  Rate  
of  Nicardipine  during  the  case  (mg/hr)   -­‐  
NITRIC_OXIDE_YN*   Nitric  Oxide  Used  for  the  Case  (Yes/No)   -­‐  
NITROGLYCERIN  BOLUS*,  
END  RATE*,  MAX  RATE*  
Total  bolus  dose  (mcg),  End  of  case  infusion  rate  
(mcg/min),  and  Highest  Infusion  rate  (mcg/min)  of  
Nitroglycerin  during  the  case  
-­‐  
NITROPRUSSIDE  END  
RATE*,  MAX  RATE*  
End  of  case  infusion  Rate  and  Highest  Infusion  Rate  
of  Nitroprusside  (mcg/kg/min)  during  the  case   -­‐  
PHENYLEPHRINE  BOLUS*,  
END  RATE*,  MAX  RATE*  
Total  bolus  dose  (mcg),  End  of  case  infusion  rate  
(mcg/min),  and  Highest  Infusion  rate  (mcg/min)  of  
Phenylephrine  during  the  case  
-­‐  
SBP  MAX*,  MIN*,  AVG,  
MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Systolic  blood  pressure  (mmHg)  
for  the  case  
300  
SBP_10min  MAX,  MIN,  
AVG,  MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  Systolic  blood  pressure  (mmHg)  
for  the  last  10  minutes  of  the  case  
300  
SpO2  MAX*,  MIN*,  AVG,  
MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  SpO2  (%)  for  the  case   100  
SpO2_10min  MAX,  MIN,  
AVG,  MED,  STD  
Maximum,  Minimum,  Average,  Median,  and  
Standard  Deviation  SpO2  (%)  for  the  last  10  
minutes  of  the  case  
100  
UOP*   Total  Urine  Output  (ml)   -­‐  
VASOPRESSIN  BOLUS*,  
END  RATE*,  MAX  RATE*  
Total  bolus  dose  (units),  End  of  case  infusion  rate  
(units/hr),  and  Highest  Infusion  rate  (units/hr)  of  
Vasopressin  during  the  case  
-­‐  
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XFUSION_RBC_ML*   Total  Red  Blood  Cells  Transfused  (ml)   -­‐  
  
Data  Preprocessing  
One  of  the  biggest  issues  with  this  data  and  other  clinical  data  is  missing  values.  For  
example,  minimum  hemoglobin  during  surgery  could  be  missing  for  a  specific  patient.  This  
missing  value  is  not  due  to  error,  but  rather  that  the  anesthesiologist  felt  the  patient  was  
normal  and  no  blood  samples  were  taken  because  the  patient  did  not  need  one.  It  should  also  
be  noted  that  the  fact  that  the  variable  is  missing  is  important  information  in  itself  and  a  
different  way  to  address  these  gaps  would  be  to  include  binary  variables  that  indicate  whether  
or  not  a  value  was  missing.  Another  way  to  address  these  gaps  for  future  work  would  be  to  fill  
them  with  clinically  normal  values  as  defined  by  domain  experts.    
Prior  to  model  development,  missing  values  were  filled  with  the  mean  value  for  the  
respective  feature,  or  filled  with  the  most  common  value  or  zero  (Table  8).  In  addition,  to  
account  for  observations  where  the  value  is  clinically  out  of  range,  values  greater  than  a  
clinically  normal  maximum  were  set  to  a  maximum  possible  value  (Table  7).  These  out  of  range  
values  were  due  to  the  data  artifact  in  the  raw  EMR  data.  For  example,  a  systolic  blood  pressure  
of  400  mmHg  is  not  clinically  possible,  however,  it  may  be  recognized  as  the  maximum  systolic  
blood  pressure  for  the  case  during  EMR  extraction.  The  data  was  then  randomly  divided  into  
training  (80%)  and  test  (20%)  data  sets,  with  equal  %  occurrence  of  in-­‐hospital  mortality.  
Training  data  was  rescaled  to  have  a  mean  of  0  and  standard  deviation  of  1  per  feature.  Test  








In  this  work,  we  were  interested  in  classifying  patients  at  risk  of  in-­‐hospital  mortality  
using  deep  neural  networks  (DNNs),  also  referred  to  as  deep  learning.  During  development  of  
DNNs,  there  are  many  unknown  model  parameters  that  need  to  be  optimized  by  the  DNN  
during  training.  These  model  parameters  are  first  initialized  and  then  optimized  to  decrease  the  
error  of  the  model’s  output  to  correctly  classify  in-­‐hospital  mortality.  This  error  is  referred  to  as  
a  loss  function.  The  type  of  DNN  used  in  this  study  is  a  feedforward  network  with  fully  
connected  layers  and  a  logistic  output.  “Fully  connected”  refers  to  the  fact  that  all  neurons  
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between  two  adjacent  layers  are  fully  pairwise  connected.  A  logistic  output  was  chosen  so  that  
the  output  of  the  model  could  be  interpreted  as  probability  of  in-­‐hospital  mortality  [0-­‐1].  To  
develop  a  DNN,  it  is  important  to  fine-­‐tune  the  hyperparameters  as  well  as  the  architecture.  We  
utilized  stochastic  gradient  descent  (SGD)  with  momentums  [0.8,  0.85,  0.9,  0.95,  0.99]  and  
initial  learning  rates  [0.01,  0.1,  0.5],  and  a  batch  size  of  200.  We  also  assessed  DNN  
architectures  of  1  to  5  hidden  layers  with  10  -­‐  300  neurons  per  layer,  and  rectified  linear  unit  
(ReLU)  and  hyperbolic  tangent  (tanh)  activation  functions.  The  loss  function  was  cross  entropy.  
We  utilized  five-­‐fold  cross  validation  with  the  training  set  (80%)  to  select  the  best  
hyperparameters  and  architecture  based  on  mean  cross  validation  performance.  These  best  
hyperparameters  and  architecture  were  then  used  to  train  a  model  on  the  entire  training  set  
(80%)  prior  to  testing  final  model  performance  on  the  separate  test  set  (20%).  
Overfitting  
While  ~50,000  examples  is  large  for  clinical  data,  it  is  small  relative  to  datasets  found  in  
deep  learning  tasks  like  vision  and  speech  recognition  where  millions  of  examples  are  available.  
Thus,  overfitting  was  a  major  concern  and  regularization  is  critical.  The  first  and  most  obvious  
solution  to  this  would  be  to  just  collect  more  data.  This  is  currently  being  addressed  by  data  
collection  efforts  at  UC  Irvine,  but  to  collect  more  data  at  a  large  enough  scale  can  take  years,  
as  it  is  limited  by  the  number  of  patients  that  come  through  the  hospital.  Thus,  early  stopping,  
L2  weight  decay,  and  dropout  were  all  used  to  address  overfitting.  Early  stopping  is  used  during  
the  training  process.  A  loss  function  is  calculated  after  each  epoch  on  a  validation  set  and  once  
the  validation  loss  starts  to  increase,  indicating  overfitting,  training  is  stopped.  The  point  at  
which  to  stop  training  depends  on  a  “patience”  parameter,  corresponding  to  the  number  of  
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epochs  to  wait  for  to  see  if  validation  loss  continues  to  increase.  For  all  models,  the  patience  
was  set  to  10.  L2  weight  decay  is  a  method  of  limiting  the  size  of  the  weights.  The  standard  L2  
weight  penalty  involves  adding  an  extra  term  to  the  loss  function  that  penalizes  the  squared  
weights,  keeping  the  weights  small  unless  the  error  derivative  is  big.  The  loss  function  used  for  
all  models  was  log  loss,  also  known  as  cross  entropy  loss.  Log  loss  is  defined  by    
𝐿 = 	  − 1𝑛	  :𝑦 ln𝑎 + (1 − 𝑦)ln	  (1 − 𝑎)?   
where  𝑛  is  the  total  number  of  examples  in  the  training  data,  the  sum  is  over  all  the  training  
inputs  𝑥  and  𝑦  is  the  corresponding  desired  output  and  𝑎  is  the  calculated  output.  The  output  
used  for  all  models  is  sigmoid.  If	  𝐿  is  the  loss  function,  then  the  new  loss  function  with  L2  
penalty  is  the  following,  where  𝑖  indicates  the  𝑖-­‐th  example:  
𝐶 = 𝐿 +	  𝜆2:𝑤DED   
We  utilized  an  L2  weight  penalty  of  0.0001.  Dropout  is  a  relatively  new  way  to  deal  with  the  
limited  data  as  compared  to  the  large  number  of  learning  parameters  seen  with  deep  neural  
networks  [57].  Neurons  are  removed  from  the  network  with  a  specified  probability  during  
training.  This  prevents  neurons  from  co-­‐adapting  too  much.    The  procedure  is  repeated  for  each  
example  at  each  training  epoch.  After  training  is  complete,  predictions  are  produced  by  
multiplying  the  weights  by  the  specified  dropout  probability.  Dropout  was  only  applied  before  
the  output  layer.  The  following  figure  describes  drop  out  and  was  taken  from  paper  by  





The  goal  of  training  was  to  optimize  model  parameters  to  decrease  classification  error  
of  in-­‐hospital  mortality.  However,  the  actual  percent  of  occurrence  of  in-­‐hospital  mortality  in  
the  data  was  low  and  thus  the  data  was  skewed.  The  %  occurrence  of  mortality  in  the  training  
dataset  was  <  1%.  To  help  with  this  skewed  distribution,  training  data  was  augmented  by  taking  
only  the  observations  positive  for  in-­‐hospital  mortality  and  adding  Gaussian  noise.  This  was  
performed  by  adding  a  random  number  taken  from  a  Gaussian  distribution  with  a  standard  
deviation  of  0.0001  to  each  feature’s  value.  This  essentially  duplicated  the  in-­‐hospital  mortality  
observations  with  a  slight  perturbation.  The  in-­‐hospital  mortality  observations  in  the  training  
data  set  were  augmented  using  this  method  to  approximately  45%  occurrence  prior  to  training.  
During  cross  validation,  this  meant  that  only  training  folds  were  augmented.  The  validation  fold  
was  not  augmented.  
  
Feature  Reduction  and  Preoperative  Feature  Experiments  
  
Experiments  to  assess  the  impact  of  1)  reducing  the  number  of  features  from  the  
clinician  chosen  87  to  45  features,  and  2)  adding  ASA  and  POSPOM  as  a  feature  were  also  
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conducted.  The  reduced  45  feature  set  was  created  by  excluding  all  “derived”  features,  
specifically  average,  median,  standard  deviation,  and  last  10  minutes  of  the  surgical  case  
features  (Table  7).  
After  choosing  the  best  performing  DNN  architecture  and  hyperparameters  with  the  complete  
87  features  data  set,  five  additional  DNNs  were  each  trained  with  the  following:    
1)   the  addition  of  ASA  as  a  model  feature  (88  features)  
2)   the  addition  of  POSPOM  as  a  model  feature  (88  features)  
3)   a  reduced  model  feature  set  (45  features)  
4)   the  addition  of  ASA  to  the  reduced  feature  set  (46  features).  
5)   the  addition  of  POSPOM  to  the  reduced  feature  set  (46  features).  
  
Model  Performance  Methods  
All  model  performances  were  assessed  on  20%  of  the  data  held  out  from  training  as  a  test  
set.  Model  performance  was  compared  to  ASA,  Surgical  Apgar,  RQI,  RSI,  POSPOM,  and  a  
standard  logistic  regression  model  using  the  same  combination  of  features  as  in  the  DNN.  ASA  
was  extracted  from  the  UCLA  preoperative  assessment  record.  Surgical  Apgar  was  calculated  
using  Gawande  et  al.10  RQI  could  not  be  calculated  using  the  downloadable  R  package  from  
Cleveland  Clinic’s  website  <  
http://my.clevelandclinic.org/departments/anesthesiology/depts/outcomes-­‐research>  due  to  
technical  issues  with  the  R  version,  and  so  RQI  log  probability  and  score  were  calculated  from  
equations  provided  in  Sigakis  et  al.43    Uncalibrated  RSI  was  calculated  using  coefficients  
provided  by  the  original  authors.  To  calculate  RSI,  all  ICD-­‐9  diagnosis  codes  for  each  patient  
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were  matched  with  an  RSI  coefficient  and  the  coefficients  were  then  summed.  POSPOM  scores  
were  extracted  from  the  PDW,  where  they  were  calculated  as  described  by  Le  Manach  et  al.14  
Each  of  the  diseases  described  by  Le  Manach  et  al.  were  extracted  as  a  binary  endpoint  from  
the  admission  ICD  codes  for  the  relevant  hospital  admission.  In  addition  to  assigning  points  
based  on  patient  co-­‐morbidities  the  POSPOM  also  assigns  points  for  the  type  of  surgery  
performed.  These  points  were  assigned  based  on  the  primary  surgical  service  for  the  given  
procedure.    
Model  performance  was  assessed  using  Area  Under  the  ROC  Curve  (AUC)  and  95%  
confidence  intervals  for  AUC  were  calculated  using  bootstrapping  with  1,000  samples.  The  F1  
score,  sensitivity,  and  specificity  were  calculated  for  different  thresholds  for  the  DNN  models,  
logistic  regression  model,  ASA,  and  POSPOM.  The  F1  score  is  a  measure  of  precision  and  recall,  
ranging  from  0  to  1.  It  is  calculated  as  𝐹1 = 2 ∗ 	   HI)JDKDLM∗I)JNOOHI)JDKDLM(I)JNOO    ,  where  precision  is  (true  
positives/predicted  true)  and  recall  is  equivalent  to  sensitivity.  Two  different  threshold  
methods  were  assessed:  1)  a  threshold  that  optimized  the  observed  in-­‐hospital  mortality  rate  
and  2)  a  threshold  based  on  the  highest  F1  score.  The  number  of  true  positives,  true  negatives,  
false  positives,  and  false  negatives  were  then  assessed  for  each  threshold  to  assess  differences  
in  the  number  of  patients  correctly  predicted  by  each  model.  
Calibration  
  
Calibration  was  performed  to  account  for  the  use  of  data  augmentation  on  the  training  
data  set  to  be  used  during  training  of  the  DNN.  This  data  augmentation  served  to  balance  
classes  in  the  training  data  set  to  approximately  45%  mortality  vs  the  true  distribution  of  
mortality  (<1%).  This  extreme  augmentation  of  the  training  data  set  classes  skewed  predicted  
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probabilities  to  be  higher  than  the  expected  probability  based  on  the  true  distribution  of  
mortality  (<1%).  Therefore,  we  performed  calibration  after  finalizing  the  model.  Calibration  was  
performed  only  on  the  test  data  set.  Calibration  of  the  DNN  predicted  probability  output  was  
performed  using  the  following  equation:  
𝐶𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑒𝑑	  𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑	  𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 = 	   11 +	  Y 1𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑	  𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 − 1Z𝑃(0)𝑃(1)  
  
,  where  𝑃(1) = 	   #	  \]K)I^)_	  `LIaNODab	  DM	  c)Ka	  #	  c)Ka	  dNaD)MaK = ef''ggf  and  𝑃(0) = 	  1 − 𝑃(1).  This  calibration  
formula  was  used  to  maintain  the  rank  of  predicted  probabilities,  and  thus  not  changing  any  
model  performance  metrics  (AUC,  sensitivity,  specificity,  or  F1  score).    
In  addition,  calibration  plots  and  Brier  scores  were  used  to  assess  calibration  of  predictions.  
Feature  Importance  
To  assess  which  features  are  the  most  predictive  in  the  DNN,  we  performed  a  feature  
ablation  analysis.  This  analysis  consisted  of  removing  model  features  grouped  by  type  of  clinical  
feature,  and  then  re-­‐training  a  DNN  with  the  same  final  architecture  as  well  as  
hyperparameters  on  the  remaining  features.  The  change  in  AUC  with  the  removal  of  each  
feature  was  then  assessed  to  evaluate  the  importance  of  each  group  of  features.  To  assess  
which  features  are  the  most  predictive  in  the  logistic  regression  model,  we  assessed  which  
features  corresponded  to  the  largest  weights.  
  
All  DNN  models  were  developed  and  applied  using  Keras.47  Logistic  regression  models  and  





The  data  consisted  of  59,985  surgical  records  total.  Patient  demographics  and  
characteristics  of  the  training  and  test  data  sets  are  summarized  in  Table  9.  The  in-­‐hospital  
mortality  rate  of  both  the  training  and  test  set  is  less  than  1%.  The  presence  of  invasive  lines  is  
also  similar  for  both  sets  (26.5%  in  training;  26.7%  in  test).  The  most  prevalent  ASA  is  3  at  49.9%  
for  both  sets.  
Table  9.  Description  of  patient  demographics  
  
   Train   Test  
#  Patients   47985   11996  
Age   56  +/-­‐  17   56  +/-­‐  94  
EBL   96  +/-­‐  539   18  +/-­‐  410  
#  with  Aline   8583   2135  
#  with  PA   1641   430  
#  with  CVC   2443   635  
ASA  Score        
1   3022   762  
2   17930   4477  
3   23960   5985  
4   2910   735  
5   144   30  
6   4   0  
Unknown   15   7  
Primary  CPT  by  Specialty        
Gastroenterology   6615  (13.8%)   1614  (13.5%)  
General  Surgery   6552  (13.7%)   1646  (13.7%)  
Urology   4005  (8.3%)   1062  (8.9%)  
Orthopaedics   3916  (8.2%)   979  (8.2%)  
Neurosurgery   3686  (7.7%)   916  (7.6%)  
Otolaryngology   3268  (6.8%)   860  (7.2%)  
Obstetrics  and  Gynecology   2630  (5.5%)   672  (5.6%)  
Vascular  Surgery   1834  (3.8%)   445  (3.7%)  
Cardiac  Surgery   1396  (2.9%)   372  (3.1%)  
Thoracic  Surgery   1095  (2.3%)   273  (2.3%)  
Other   8497  (17.7%)   2049  (17.1%)  
Unknown   4491  (9.4%)   1108  (9.2%)  
        
AKI        
Class  1   2501  (  5.21  %)   622  (  5.19  %)  
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Class  2   369  (  0.77  %)   99  (  0.83  %)  
Class  3   1001  (  2.09  %)   246  (  2.05  %)  
Null   30616  (  63.8  %)   7689  (  64.1  %)  
Reintubation   548  (  1.14    %)   159  (  1.33  %  )  
Mortality   389  (  0.81  %  )   87  (  0.73  %  )  
  
The  final  DNN  architecture  consists  of  four  hidden  layers  of  300  neurons  per  layer  with  
rectified  linear  unit  (ReLu)  activations  and  a  logistic  output.  The  DNN  was  trained  with  dropout  
probability  of  0.5  between  all  layers,  L2  weight  decay  of  0.0001,  and  a  learning  rate  of  0.01  and  
momentum  of  0.9.    
Model  Performance  
All  performance  metrics  reported  below  refer  to  the  test  data  set  (n  =  11,997).  ROC  
curve  and  AUC  results  are  shown  in  Figure  2.  All  logistic  regression  models  (LR)  and  all  DNNs  
had  higher  AUCs  than  POSPOM  (0.74  (95%  CI,  0.68  –  0.79))  and  Surgical  Apgar  (0.58  (95%  CI,  
0.52  –  0.64))  for  predicting  in-­‐hospital  mortality  (Figure  3).    All  DNNs  had  higher  AUCs  than  LRs  
for  each  combination  of  features  except  for  the  reduced  feature  set  with  POSPOM  (LR  0.90  
(95%  CI,  0.86  –  0.93)  vs  DNN  0.90  (95%  CI,  0.87  –  0.93)).  In  addition,  reducing  the  feature  set  
from  87  to  45  features  did  not  reduce  the  DNN  model  AUC  performance  and  the  addition  of  
ASA  and  POSPOM  as  features  modestly  improved  the  AUCs  of  both  the  full  and  reduced  feature  
set  DNN  models.  The  highest  DNN  AUC  result  was  the  DNN  with  reduced  feature  set  and  ASA  
(0.91  (95%  CI,  0.88  –  0.93)).  The  highest  clinical  risk  score  AUC  was  RSI  (0.97  (95%  CI,  0.94  –  
0.99))  and  the  highest  LR  AUCs  were  the  LR  with  reduced  feature  set  and  ASA  (0.90  (95%  CI,  

















Figure  3.  ROC  Curve  and  AUC  (95%  CI)  results  for  in-­‐hospital  mortality  models  and  scores.  
  
For  comparison  of  F1  scores,  sensitivity  and  specificity  at  different  thresholds,  DNN  with  
original  87  features  (DNN),  DNN  with  a  reduced  feature  set  and  POSPOM  (DNNrfsPOSPOM),  and  
DNN  with  a  reduced  feature  set  and  ASA  (DNNrfsASA)  are  compared  to  ASA,  POSPOM,  logistic  
regression  with  original  87  features  (LR),  logistic  regression  with  a  reduced  feature  set  and  
POSPOM  (LRrfsPOSPOM),  and  logistic  regression  with  a  reduced  feature  set  and  ASA  (LRrfsASA)  
(Table  4).  If  we  choose  a  threshold  that  optimizes  the  observed  in-­‐hospital  mortality  rate,  the  
thresholds  (%  observed  mortality)  for  POSPOM,  ASA,  and  LR,  LRrfsPOSPOM,  LRrfsASA  are  10  (93.1%),  
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3  (97.7%),  0.00015  (98.9%),  0.002  (97.7%),  and  0.0034  (96.66%),  respectively.  The  thresholds  
for  DNN,  DNNrfsPOSPOM  and  DNNrfsASA  are  0.05  (98.9%),  0.2  (96.6%)  and  0.22  (96.6%),  
respectively.  At  these  thresholds,  POSPOM,  ASA,  LR,  LRrfsPOSPOM,  LRrfsASA,  DNN,  DNNrfsPOSPOM  and  
DNNrfsASA  ,  all  have  high  and  comparable  sensitivities.  The  DNN  with  the  highest  AUC  DNNrfsASA  
had  a  sensitivity  of  0.97  (95%  CI,  0.92  –  1)  and  specificity  of  0.64  (95%  CI,  0.64  –  0.65)  and  the  
LR  with  the  highest  AUC  LRrfsASA  had  a  sensitivity  of  0.97  (95%  CI,  0.92  –  1)  and  specificity  of  0.64  
(95%  CI,  0.63  –  0.65).  However,  all  DNNs  reduced  false  positives  while  maintaining  the  same  or  
similar  number  of  false  negatives.  DNN  with  all  87  original  features  decreased  the  number  of  
false  positives  compared  to  LR  from  11,873  to  9,169  patients.  DNNrfsASA  decreased  the  number  
of  false  positives  compared  to  LRrfsASA  from  4,332  patients  to  4,241  patients;  and  compared  to  
POSPOM  and  ASA  from  9,169  patients  and  6,666  patients,  respectively.    
If  we  choose  a  threshold  that  optimizes  precision  and  recall  via  the  F1  score,  the  
thresholds  for  POSPOM,  ASA,  LR,  LRrfsPOSPOM,  and  LRrfsASA  are  higher  at  20,  5,  0,1,  0.1,  and  0.1,  
respectively  (Table  4).  All  the  thresholds  for  DNN,  DNNrfsPOSPOM,  and  DNNrfsASA  also  increased  to  
0.3,  0.4,  and  0.3,  respectively.  The  highest  F1  scores  were  comparable  for  ASA,  LRrfsASA,  and  
DNNrfsASA  at  0.24  (95%  CI,  0.14  –  0.35),  0.26  (95%  CI,  0.18  –  0.33)  and  0.22  (95%  CI,  0.12  –  0.30).  
However,  DNNrfsASA  had  a  lower  number  of  false  positives  at  35  patients  compared  to  LRrfsASA  
115  patients.  
Calibration  
For  comparison  of  calibration,  Brier  scores  and  calibration  plots  were  assessed  for  LR,  
DNNrfsASA,  and  calibrated  DNNrfsASA.  DNNrfsASA  had  the  worst  Brier  score  of  0.0352,  and  LR  had  
the  best  score  of  0.0065.  However,  the  calibrated  DNNrfsASA  had  a  comparable  Brier  score  of  
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0.0071.  Calibration  of  DNNrfsASA  shifted  the  best  thresholds  for  observed  mortality  optimization  
and  F1  optimization  from  0.2  and  0.4  to  0.0018  and  0.0048,  respectively.  
Feature  Importance  
To  assess  feature  importance,  we  assessed  the  decrease  in  AUC  for  the  removal  of  
groups  of  features  from  the  best  DNN  (DNNrfsasa)  (Figure  4).  For  the  analysis,  13  groups  were  
used  (Age,  Anesthesia,  ASA,  Input,  BP,  Output,  Vasopressor,  Vasodilator,  Labs,  HR,  Invasive  
Line,  Inotrope,  and  PulseOx).  Labs,  ASA,  anesthesia  type,  blood  pressure,  and  vasopressor  
administration  were  the  top  features  in  this  analysis.  To  assess  feature  importance,  we  
assessed  the  weights  for  the  logistic  regression  model  (LRrfsASA).  ASA  had  the  highest  weight.  In  
addition,  similar  to  the  DNN,  vasopressin,  hemoglobin,  presence  of  arterial  or  pulmonary  
arterial  line,  and  sevo  administration  are  found  in  the  top  10  weights.  (Figure  5)  
  
Figure  4.  Feature  ablation  results  for  DNN  models.  






























Figure  5.  Logistic  regression  models  coefficients.  
  
We  have  also  developed  a  website  application  that  performs  predictions  for  DNNrfsASA  
and  DNNrfs  on  a  given  data  set.  The  application  as  well  as  downloadable  model  package  are  
available  at  <risknet.ics.uci.edu>.  





































































PREDICTING  POSTOPERATIVE  OUTCOMES:  ACUTE  KIDNEY  INJURY,  
REINTUBATION,  AND  MORTALITY  
 
Building  off  our  previous  work  described  above,  we  were  interested  in  predicting  which  
patients  were  at  risk  of  poor  postoperative  outcomes:  acute  kidney  injury  (AKI)  and  
reintubation,  as  well  as  mortality.    
  
Data  Description  
Data  used  in  this  study  was  equivalent  to  the  previously  described.  
Model  Endpoint  Definition  
The  occurrence  of  an  in-­‐hospital  mortality  was  extracted  as  a  binary  event  [0,  1]  and  
described  previously.  Acute  kidney  injury  (AKI)  was  determined  based  upon  the  change  from  
the  patient’s  baseline  serum  creatinine  (CrS)  as  described  in  the  Acute  Kidney  Injury  Network  
(AKIN)  criteria.  Patients  were  defined  as  having  AKI  if  they  met  criteria  for  any  of  the  AKIN  
stages  based  upon  changes  in  their  Cr  (e.g.  had  a  CrS  more  than  1.5  times  their  baseline).  
Patients  who  lacked  either  a  preoperative  or  postoperative  Cr  were  excluded  only  from  the  AKI  
and  any  event  models.  Postoperative  reintubation  was  determined  by  documentation  of  an  
endotracheal  tube  or  charting  of  ventilator  settings  by  a  respiratory  therapist  following  surgery.    
Model  Input  Features  and  Data  Preprocessing  
All  data  preprocessing  and  input  features  were  replicated  in  this  study  per  our  previous  
work.  New  to  this  study  was  the  addition  of  6  new  features:  minutes  of  case  time  spent  with  
mean  arterial  pressure  (MAP)  <  40,  45,  50,  55,  60,  and  65  mmHg.  These  new  MAP  features  were  
added  as  potentially  relevant  features  per  studies  showing  the  importance  of  low  blood  
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pressure  to  the  risk  of  AKI  and  myocardial  infarction.22,49  For  this  model,  given  the  addition  of  6  
new  features,  we  also  chose  to  remove  features  with  a  Pearson’s  correlation  >  0.9  with  other  
features  and  were  thus  left  with  a  reduced  feature  set  (RFS)  of  44  features  total.  Thus,  while  the  
overall  architecture  of  this  model  is  similar  to  aforementioned  model  to  predict  mortality,  the  
various  models  here  have  somewhat  different  input  features.    
  
Model  Development  
We  utilized  five-­‐fold  cross  validation  with  the  training  set  (80%)  to  select  for  the  best  
performing  deep  neural  network  (DNN)  models’  hyperparameters  and  architecture.  The  
hyperparameters  assessed  were  number  of  hidden  layers  (1  to  5),  number  of  neurons  (10  to  
100),  learning  rate  (0.01,  0.1),  and  momentum  (0.5,  0.9).  To  avoid  overfitting,  we  also  utilized  
L2  regularization  (0.001,  0.0001)  and  dropout  probability  (0,  0.5,  0.9)46,50.  These  
hyperparameters  and  architecture  were  then  used  to  train  a  model  on  the  entire  training  set  
(80%)  prior  to  testing  final  model  performance  on  the  separate  test  set  (20%).  For  patients  
without  a  preoperative  baseline  Cr  and/or  a  postoperative  Cr,  we  could  not  determine  
postoperative  AKI.  Those  patients  were  excluded  from  training  for  the  individual  AKI  models  
and  the  combined  models.  In  total  that  amounted  to  exclusion  of  38,305  patients  or  63.8%  of  
the  total  sample.    
Individual  Models  to  Predict  Each  Postoperative  Outcome  Separately  
Similar  to  our  previous  work,  three  separate  DNN  models  were  created  with  each  
predicting  one  postoperative  outcome  of  interest:  in-­‐hospital  mortality,  acute  kidney  injury,  
reintubation.  A  logistic  output  was  chosen  so  that  the  output  of  each  outcomes  model  could  be  
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interpreted  as  probability  of  each  postoperative  outcome  of  interest  [0-­‐1].  We  also  assessed  
DNN  architectures  of  3  to  5  hidden  layers  with  [90,  100,  300,  400]  neurons  per  layer,  and  
rectified  linear  unit  (ReLU)  and  hyperbolic  tangent  (tanh)  activation  functions.  The  loss  function  
was  cross  entropy.  To  deal  with  the  highly  unbalanced  data  sets,  we  also  utilized  data  
augmentation  during  training  per  our  previous  work  with  prediction  of  in-­‐hospital  mortality.  
Observations  positive  for  reintubation  or  in-­‐hospital  mortality  were  augmented  100  fold.  
Observations  positive  for  AKI  were  augmented  3  fold.  Augmentation  was  done  by  adding  
Gaussian  noise  taken  from  a  Gaussian  distribution  with  a  SD  of  0.0001.  
Combined  Model  to  Predict  All  Postoperative  Outcomes  
To  assess  if  a  model  could  leverage  the  relationship  between  the  three  outcomes  (i.e.  
multitask  learning),  we  also  created  combined  models  that  output  probabilities  of  all  three  
outcomes  at  once.  The  same  hyperparameters  as  the  individual  models  were  assessed,  with  the  
exception  of  the  use  of  a  batch  size  of  100.  
Stacked  “Any”  Postoperative  Outcome  Model  
We  were  also  interested  in  predicting  the  probability  of  the  occurrence  of  any  of  the  
three  postoperative  outcomes.  For  the  combined  DNN  model,  we  took  the  average  of  the  
predicted  probability  outputs  for  each  outcome  (Figure  6).  In  other  words,  each  predicted  
probability  was  given  equal  weight.  The  averaged  value  was  considered  as  the  probability  of  
any  of  the  3  outcomes  occurring.  For  the  individual  outcome  models  (DNN  and  LR)  we  took  the  
predicted  probability  of  each  respective  outcome  model  per  equivalent  feature  set  inputs  and  
averaged  the  three  values  (Figure  6).  For  example,  the  outputs  of  each  of  the  models  for  AKI,  
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reintubation,  and  mortality  with  a  reduced  feature  set  were  averaged  to  represent  the  
probability  of  any  outcome  occurring.  
  
Figure  6.  Summary  figure  describing  the  stacked  “any”  postoperative  outcome  models  for  the  combined  
deep  neural  networks  (DNN  Combined)  trained  to  output  probabilities  of  all  3  outcomes  vs  the  deep  
neural  networks  (DNN  Individual)  and  logistic  regression  (LR)  models.  
  
Feature  Reduction  and  Clinically  Significant  Feature  Addition  Experiments  
After  choosing  the  best  performing  DNN  architectures  for  the  reduced  features  set  
(RFS),  we  also  assessed  the  performance  of  models  with  two  other  input  feature  sets:  1)  
original  46  features  set  (OFS)  and  2)  OFS  plus  the  addition  of  6  new  MAP  features  (OFS  +  MAP).  
This  was  done  to  assess  if  the  reduction  of  features  improved  performance  compared  to  a  
model  with  more  features,  and  also  to  assess  if  the  addition  of  the  clinically  significant  MAP  
features  not  used  in  previous  improved  performance  overall.  
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Model  Performance  Methods  
All  model  performances  were  assessed  on  20%  of  the  data  held  out  from  training  as  a  
test  set.  Those  patients  without  an  AKI  label  were  excluded  from  evaluation  of  test  set  results  
for  AKI,  but  not  for  in-­‐hospital  mortality,  reintubation,  or  any  outcome  results.  This  is  due  to  the  
input  features  of  each  model  independence  from  the  determination  of  AKI,  and  so  all  test  
patients  can  have  an  AKI  model  predicted  probability  even  if  AKI  class  is  unknown.  Model  
performance  and  comparison  was  performed  similar  to  our  previous  work,  with  the  addition  of  
average  precision  (AP)  and  the  McNemar’s  test.    
McNemar’s  Test  to  Compare  Model  Accuracy  
To  compare  the  predictions  of  the  DNN  and  LR  models  to  each  other,  we  utilized  
McNemar’s  test.51  McNemar’s  test  compares  the  number  of  correctly  predicted  samples  vs  
wrongly  predicted  samples  and  where  they  do  and  do  not  predict  the  same  label.  If  the  p  value  
of  McNemar’s  test  is  significant,  we  can  reject  the  null  hypothesis  that  the  2  models  have  the  
same  classification  performance.  McNemar’s  test  was  performed  using  the  freely  available  
package  MLxtend.51  
All  neural  network  models  were  developed  using  Keras.47  All  performance  metrics,  except  for  
McNemar’s  Test,  and  logistic  regression  models  were  developed  using  scikit-­‐learn.48  
  
Results  
Patient  characteristics  have  been  previously  described  in  Table  9.  The  final  model  
hyperparameters  are  described  in  Table  10  below.  
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Table  10.  Final  postoperative  outcomes  models  hyperparameters.  
  
Individual  Model  Performance  
  
As  a  baseline,  models  were  created  to  predict  each  outcome  separately  (i.e.  AKI,  
mortality,  reintubation  or  any  outcome)  using  a  DNN  (DNN  OFS).  The  models  all  performed  well  
with  AUCs  of  0.780  (95%  CI  0.763-­‐0.796)  for  AKI,  0.879  (95%  CI  0.851-­‐0.905)  for  reintubation,  
0.895  (95%  CI  .854-­‐0.930)  for  mortality  and  0.866  (95%  CI  0.855-­‐0.878)  for  any  outcome.  These  











Table  11.  AUC  (95%  confidence  intervals)  for  all  DNN  and  LR  models  as  well  as  risk  scores  for  all  
outcomes.  
  
Each  model  was  also  evaluated  for  each  feature  set  combination  of  original  feature  set  (OFS),  OFS  +  the  minimum  
MAP  features  (OFS  +  MAP),  and  reduced  feature  set  (RFS).  Note  that  for  the  LR  and  individual  models,  there  is  one  
model  per  outcome  and  the  predicted  outcome  probabilities  from  each  model  is  stacked  to  predict  any  outcome.  
For  the  combined  models,  there  is  one  model  for  all  3  outcomes  and  those  probabilities  are  stacked  to  predict  any  
outcome.    
*It  should  be  noted  that  AKI  labels  were  only  available  for  4307  of  the  test  patients,  and  so  all  AUCs  reflect  results  
for  only  those  patients  with  AKI  labels.  
**  RQI  was  calculated  on  5,591  test  patients  (63  Reintubation;  38  Mortality,  491  Any  Label);  and  on  2,319  test  
patients  with  AKI  labels    (445  positive)  
***  RSI  was  calculated  on  11,939  test  patients  (159  Reintubation;  86  Mortality,  1066  Any  Label);  and  on  4,294  test  
patients  with  AKI  labels    (967  positive)  
  
Combined  Model  Performance  
In  an  effort  to  improve  model  performance  we  attempted  to  train  a  combined  model  
that  would  output  the  risk  of  each  individual  outcome.  The  thought  was  that  in  using  a  model  
that  had  information  on  all  of  the  outcomes  the  model  could  “learn”  from  one  outcome  in  
order  to  predict  the  others.  In  fact,  these  models  did  not  perform  better  than  the  original  
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model:  AUC  0.785  (95%  CI  0.767-­‐0.801)  for  AKI,  0.858  (95%  CI  0.829-­‐0.886)  for  reintubation,  
0.907  (95%  CI  0.872-­‐0.938)  for  mortality  and  0.865  (95%  CI  0.854-­‐0.877)  for  any  outcome.    
McNemar’s  Test  
  
In  order  to  assess  the  ability  of  the  DNN  as  compared  to  LR,  we  used  the  McNemar  Test  
to  look  at  overall  model  accuracy.  All  results  were  based  on  the  threshold  that  optimized  the  F1  
score  for  that  model.  These  results  are  shown  in  Table  12.  In  general,  we  see  that  the  DNN  
models  and  the  LR  models  do  perform  significantly  differently.  
Table  12.  McNemar's  Test  Results  
  
  
PREDICTING  POST-­‐LIVER  TRANSPLANT  MORTALITY  
 
Liver  transplantation  is  the  definitive  treatment  for  irreversible  liver  failure,  with  
thousands  of  lives  saved  each  year  in  the  Unites  States  through  deceased  donor  organ  
donation.  Unfortunately,  with  the  demand  for  donor  organs  far  exceeding  the  supply,  
thousands  of  patients  die  waiting  for  this  life  saving  procedure.52As  such,  the  development  of  
predictive  models  of  post-­‐transplant  mortality  is  crucial  to  avoid  transplanting  an  individual  
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with  an  unacceptably  low  probability  of  post-­‐transplant  survival.  While  the  prediction  of  pre-­‐
operative  mortality  among  those  waiting  for  an  organ  has  been  quite  successful  with  the  
adoption  of  the  Model  for  End-­‐Stage  Liver  Disease  (MELD)  score  to  prioritize  organ  allocation,  
the  accurate  prediction  of  post-­‐transplant  mortality  has  been  difficult  and  less  successful.53–56    
Two  of  the  most  commonly  cited  risk  models  are  the  Balance  of  Risk  (BAR)  score  and  the  
Survival  outcomes  following  liver  transplantation  (SOFT)  score,  both  of  which  predict  90-­‐day  
post-­‐liver  transplant  mortality  using  United  Network  of  Organ  Sharing  (UNOS)  registry  data.57,58  
The  SOFT  score  incorporated  a  combination  of  18  recipient  and  donor  variables  and  achieved  a  
c-­‐statistic  of  0.7,  and  the  BAR  score  achieved  a  C-­‐statistic  of  0.7  using  a  combination  of  just  6  
recipient  and  donor  variables.  Despite  the  popularity  of  these  models  in  academic  circles,  their  
clinical  use  has  been  limited  due  to  their  modest  discriminative  performance.    
In  this  study,  we  attempted  to  develop  a  DNN  model  using  pre-­‐operative  variables  from  the  




All  data  for  this  study  were  extracted  from  the  standard  transplant  analysis  and  research  
(STAR)  dataset  which  contains  patient-­‐level  data  for  all  transplants  in  the  Unites  States  reported  
to  the  Organ  Procurement  and  Transplantation  Network  (OPTN)  since  October  1,  1989.  The  
database  has  been  used  in  numerous  important  studies  of  transplantation  and  contains  data  on  
pre-­‐transplant  variables  pertaining  to  the  recipient,  donor  variables  reported  from  the  organ  
procurement  organization,  as  well  as  post-­‐transplantation  outcome  data.  The  OPTN  mortality  
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data  are  linked  by  UNOS  to  the  Social  Security  Death  Master  file  to  improve  ascertainment  of  
recipient.  59  
The  study  sample  included  adult  deceased  donor  liver  transplants  performed  from  2005  
to  2015.  Transplants  performed  from  2016  onwards  were  not  included  in  this  analysis  to  ensure  
adequate  time  for  ascertainment  of  outcome  data,  and  transplants  performed  prior  to  2005  
were  excluded  because  1)  transplants  before  2002  were  performed  prior  to  implementation  of  
the  MELD  score  allocation  system,  and  2)  data  on  several  predictor  variables  were  either  not  
reported  or  were  inconsistently  recorded  prior  to  that  time.    Exclusion  criteria  included  age  less  
than  18  years,  living  donor  transplantation  (n=2,347),  multiple-­‐organ  transplantation  (n=5,267),  
as  well  as  those  lost  to  follow-­‐up  within  90  days  post-­‐transplantation  (n=70)  as  these  cases  
were  excluded  in  the  development  of  the  SOFT  score  and  BAR  score.  For  patients  who  
underwent  more  than  one  liver  transplantation  (n=3,503),  we  included  each  of  the  
transplantations  in  the  analysis  as  did  other  comparable  prediction  models.  The  study  sample  
included  split  liver  as  well  as  Donation  after  Cardiac  Death  (DCD)  donors.    In  sum,  we  analyzed  
57,544  recipients.    
Model  Endpoint  Definition  
The  occurrence  of  death  within  90  days  from  transplantation  was  extracted  as  a  binary  
event  [0,  1].    An  event  occurred  if  the  value  of  the  variable  “pstatus”  from  the  STAR  dataset  was  
equal  to  “1”  and  the  variable  “ptime”  was  less  than  or  equal  to  90.  The  variable  “pstatus”  
indicates  whether  the  recipient  had  died  post-­‐transplant,  and  the  variable  “ptime”  indicates  the  
time  from  transplantation  to  either  death  or  censoring.  These  variables  are  based  on  the  
combination  of  mortality  data  from  OPTN  database  as  well  as  verified  external  sources  of  death  
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(described  above),  and  not  based  on  the  variable  “PX_STAT”  which  only  accounts  for  death  as  
documented  by  the  OPTN  alone.    
Model  Input  Features  
The  original  STAR  dataset  contained  395  variables,  many  of  which  were  not  considered  
for  inclusion  in  the  model.  Variables  that  were  excluded  from  model  development  included  
those  pertaining  to  post-­‐transplant  data,  living  donor  transplants,  multi-­‐organ  transplants,  and  
identifier  code  variables.  Variables  with  zero  or  near  zero  variances,  high  levels  of  missing  data  
(>98%)  or  those  that  were  highly  correlated  to  other  variables  (r>0.99)  were  removed.  A  few  
variables  with  >50%  missing  data  combined  with  low  clinical  significance  based  on  domain  
experts  were  not  analyzed.  This  resulted  in  202  features  including  132  recipient  variables  and  
70  donor-­‐related  variables  (Appendix  A).  To  further  reduce  the  feature  set,  variables  with  
greater  than  50  percent  missing  data  or  those  containing  greater  than  95%  zero  values  were  
removed  and  the  remaining  variables  comprised  a  reduced  feature  set  (RFS).  
     While  most  of  the  categorical  features  had  a  simple  binary  encoding  (Appendix  A),  
categorical  features  identified  by  domain  expert  that  required  more  complex  encoding  were  
encoded  based  on  clinician  judgment.  For  example,  the  variable  “DIAG”,  which  indicates  a  
recipient’s  primary  liver  disease  diagnosis  at  transplantation,  contains  70  possible  unique  
diagnosis  codes.  Rather  than  creating  70  new,  binary  categorical  features,  groups  of  diagnosis  
codes  were  used  to  collapse  the  70  unique  codes  into  11  new  categorical  features.  
BAR  Score  and  SOFT  Score  
The  BAR  score  and  SOFT  score  are  two  models  used  to  predict  90-­‐day  post-­‐liver  
transplant  survival  using  UNOS  data.  To  compare  the  discriminative  ability  of  the  DNN  to  that  of  
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these  models,  the  BAR  score  and  SOFT  score  were  calculated  for  recipients  in  this  dataset.  Data  
on  cold  ischemia  time  was  missing  for  2.8%  of  recipients,  and  therefore,  the  BAR  score  could  
not  be  calculated  for  these  subjects.  The  amount  of  missing  data  for  other  variables  was  <0.1%,  
and  these  cases  were  removed  from  the  calculation  of  the  BAR  score’s  area  under  the  receiver  
operating  characteristics  curve  (AUC).  Missing  data  for  the  SOFT  score  was  handled  by  assigning  
the  missing  value  to  the  reference  group  category  as  indicated  by  the  scoring  methodology.  
One  of  the  18  variables  that  comprises  the  original  SOFT  score  is  the  presence  of  a  portal  bleed  
within  48  hours  of  transplantation.  This  variable  was  not  available  in  the  STAR  dataset  and  
therefore  was  not  included  in  the  calculated  SOFT  score.  In  our  analysis,  we  calculated  the  SOFT  
score  using  the  remaining  17  components.  
Data  Preprocessing  
Prior  to  model  development,  missing  values  were  imputed  with  the  mean  value  for  
continuous  variables  and  with  0  for  categorical  variables.  The  data  were  then  randomly  divided  
into  training  (80%)  and  test  (20%)  data  sets.  The  training  data  was  rescaled  to  have  a  mean  of  0  
and  standard  deviation  of  1  per  feature.  The  test  data  was  rescaled  to  the  training  mean  and  
standard  deviation.     
“Soft”  Binning  Features  
Besides  following  the  standard  approach  of  normalizing  individual  input  features  we  
also  experimented  with  a  novel  idea  that  we  will  refer  to  as  "soft  binning".  Similar  to  
standard/"hard"  binning,  the  data  representation  of  any  feature  is  replaced  by  a  fixed  number  
of  bins,  containing  numbers  between  0  and  1.  Ordinary  binning  discretizes  a  feature  by  
representing  it  as  a  single  "1"  in  one  bin,  and  zeroes  in  all  other  bins,  potentially  resulting  in  loss  
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of  information  and  making  the  classification  task  harder.  "Soft"  binning  is  the  most  straight-­‐
forward  generalization  of  binning  without  loss  of  information,  where  two  bins  are  assigned  
values  in  the  range  of  0  to  1,  which  sum  to  one.  These  values  encode  the  fraction  to  which  the  
feature's  value  falls  into  the  given  bins.  For  example,  if  in  standard  binning  a  value  would  fall  
exactly  on  the  boundary  between  two  bins,  then  it  would  instead  be  represented  as  two  
neighboring  entries  of  "0.5"  in  the  neighboring  bins  in  "soft"  binning.  Our  motivation  for  
creating  "soft"  binning  was  that  binning  alleviates  the  burden  for  the  neural  network  to  learn  




The  primary  aim  of  the  study  was  to  classify  recipients  with  90-­‐day  post-­‐liver  transplant  
mortality  using  deep  neural  networks  (DNNs),  also  referred  to  as  deep  learning.  The  type  of  
DNN  used  in  this  study  was  a  feedforward  network  with  fully  connected  layers  and  a  logistic  
output.  A  logistic  output  was  chosen  so  that  the  output  of  the  model  could  be  interpreted  as  
probability  of  mortality  [0-­‐1].  We  utilized  stochastic  gradient  descent  with  momentum  [0.2,  0.5,  
0.9]  and  initial  learning  rates  [0.01,  0.001,  0.1],  and  a  batch  size  of  500.  We  also  assessed  DNN  
architectures  of  1  to  5  hidden  layers  with  [10,  50,  100,  110,  115,  120,  130,  140,  150]  neurons  
per  layer,  and  rectified  linear  unit  (ReLU)  activation  functions.  The  loss  function  was  cross  
entropy.  To  minimize  overfitting,  we  utilized  three  methods:  1)  early  stopping  with  a  patience  
of  10  epochs,  2)  L2  weight  decay,  and  3)  dropout.46,50  We  assessed  L2  weight  penalties  of  [0.01,  
0.001,  0.0001]  and  dropout  was  applied  to  all  layers  with  a  probability  of  [0,  0.2,  0.5,  0.9].  We  
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utilized  five-­‐fold  cross  validation  with  the  training  set  (80%)  to  select  the  best  hyperparameters  
and  architecture  based  on  mean  cross  validation  performance.  These  best  hyperparameters  
and  architecture  were  then  used  to  train  a  model  on  the  entire  training  set  (80%)  prior  to  
testing  final  model  performance  on  the  separate  test  set  (20%).    
  
Model  Performance  Methods  
All  model  performances  were  assessed  on  20%  of  the  data  held  out  from  training  as  a  
test  set.  Model  performance  was  assessed  using  area  under  the  receiver  operating  curve  (AUC)  
and  were  compared  to  the  BAR  score  and  the  SOFT  score.    
Results  
  
Best  neural  network  hyperparameters  for  each  DNN  and  feature  set  are  described  in  
Table  13.  





All  performance  metrics  reported  below  refer  to  the  test  dataset.  
The  best  DNN  model  (DNN  with  OFS  +  softbin)  had  a  higher  AUC  (0.703  (95%CI:  0.682  -­‐  
0.726))  compared  to  that  for  the  BAR  score  and  SOFT  score  models  (0.655  (95%CI:  0.633  -­‐  
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0.678);  0.688  (95%CI:  0.667  -­‐  0.711)),  respectively  on  the  11,207  patients  with  available  BAR  
scores  (Table  14).  In  addition,  softbin  preprocessing  of  input  features  improved  performance  of  
both  the  OFS  and  RFS  models.  While  the  best  DNN  had  a  significantly  higher  AUC  than  the  BAR  
score,  the  DNN  did  not  achieve  a  significantly  higher  AUC  than  the  SOFT  score.  The  DNN  with  
the  reduced  feature  set  and  softbin  preprocessing  (DNN  with  RFS  +  softbin)  performed  
comparably  (AUC  0.702  (95%CI:0.68  -­‐  0.725))  to  the  DNN  with  OFS  +  softbin.  
Table  14.  AUC  (95%  confidence  intervals)  for  all  DNN  models  as  well  as  BARscore  and  SOFTscore,  
   AUC  (95%  CI)  
   n  =  11,509   n  =  11,207*  
BARscore*   0.655  (0.633  -­‐  0.678)   0.655  (0.633  -­‐  0.678)  
SOFTscore   0.691  (0.671  -­‐  0.714)   0.688  (0.667  -­‐  0.711)  
DNN  w/  Original  202  
Features  Set  (OFS)   0.697  (0.678  -­‐  0.72)   0.695  (0.675  -­‐  0.717)  
DNN  w/  OFS  +  softbin   0.708  (0.689  -­‐  0.73)   0.703  (0.682  -­‐  0.726)  
DNN  w/  Reduced  140  
Features  Set  (RFS)   0.699  (0.681  -­‐  0.722)   0.698  (0.679  -­‐  0.72)  
DNN  w/  RFS  +  softbin   0.707  (0.688  -­‐  0.729)   0.702  (0.68  -­‐  0.725)  
*BARscore  was  calculated  on  11,207  test  patients  due  to  missing  data.  
By  choosing  a  threshold  that  optimizes  the  F1  score,  the  SOFT  score  achieved  the  
highest  F1  score  (0.215  (95%CI:0.191  -­‐  0.238))  at  a  threshold  of  20,  with  sensitivity  and  
specificity  of  0.375  (95%CI:0.336  -­‐  0.416)  and  0.881  (95%CI:0.875  -­‐  0.888),  respectively  for  the  
11,207  patients  with  available  BAR  scores.  This  score  was  not  significantly  different  from  the  
highest  F1  score  among  the  DNN  models,  which  was  achieved  by  DNN  with  RFS  +  softbin  (0.21  
(95%CI:0.187  -­‐  0.236))  at  a  threshold  of  0.106,  with  sensitivity  and  specificity  of  0.331  
(95%CI:0.296  -­‐  0.369)  and  0.898  (95%CI:0.892  -­‐  0.904),  respectively.  At  this  threshold,  the  SOFT  
score  had  slightly  more  true  positives  compared  to  the  DNN  model  (223  vs  199)  as  a  result  of  
the  higher  sensitivity,  but  with  more  false  positives  (1194  vs  1099)  as  a  result  of  the  lower  
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specificity.  The  best  DNN  model  based  on  AUC,  namely  DNN  with  OFS  +  softbin,  had  a  
comparable  F1  score  0.209  (95%CI:0.184  -­‐  0.234)  at  a  threshold  of  0.113.    
Overall,  the  results  demonstrated  that  a  DNN  can  be  utilized  to  predict  90-­‐day  post-­‐liver  
transplant  mortality  using  UNOS  registry  data.  While  the  AUC  for  the  best  performing  DNN  
(DNN  with  OFS  +  softbin)  was  the  highest  among  the  tested  models,  significantly  outperforming  
the  BAR  score,  it  did  not  achieve  significantly  higher  performance  compared  to  the  SOFT  score.  
  
PREDICTING  INTRAOPERATIVE  HYPOTENSION  USING  THE  ARTERIAL  
BLOOD  PRESSURE  WAVEFORM  
 
In  collaboration  with  Edwards  Lifesciences,  we  developed  a  continuous  predictor  of  risk  
of  hypotension,  also  known  as  Hypotension  Probability  Index  (HPIÔ).  It  has  been  shown  that  
even  just  one  minute  of  intraoperative  hypotension  can  lead  to  increased  risk  of  poor  
postoperative  outcomes.22,49  Thus,  there  is  a  need  in  critical  care  monitoring  to  help  clinicians  
identify  the  onset  of  a  hypotensive  event.  
  
Data  Description  
Data  used  in  the  development  and  testing  of  HPI  came  from  Edwards  Lifesciences  
internal  database  from  clinical  studies  as  well  as  from  the  MIMIC  II  Waveform  Database  for  a  
total  of  1,280  patients.5  954  patients  came  from  the  Edwards  internal  database.  These  patients  
included  both  surgical  and  ICU  patients,  and  represented  a  wide  range  of  surgical  procedures  
such  as  cardiac  bypass  and  liver  transplants  and  various  acute  conditions  such  as  sepsis.  326  
patients  came  from  the  MIMIC  II  database,  and  these  were  all  ICU  patients.  302  patients  were  
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The  first  task  was  to  define  a  hypotensive  event.  A  hypotensive  event  was  defined  as  
MAP  <  65  mmHg  for  at  least  1  minute.  Non  hypotension  was  defined  as  MAP  >  75  mmHg  and  at  
least  20  minutes  away  from  the  start  or  end  of  an  event.  These  definitions  were  settled  on  after  
discussion  with  domain  experts  as  well  as  review  of  the  literature  looking  at  all  currently  used  
definitions  for  hypotension  in  the  clinical  and  research  setting.60  It  should  be  noted  that  the  
model  features  and  results  are  proprietary  to  Edwards  Lifesciences.  Due  to  the  proprietary  
nature  of  this  model,  description  of  the  methods  and  all  results  being  shown  have  been  either  
published  or  are  currently  accepted  conference  abstracts.61    
  
Model  Input  Features:  Description  of  Arterial  Blood  Pressure  Waveform  Features  
After  defining  hypotensive  events,  feature  selection  was  performed  to  select  the  best  
features  from  the  radial  arterial  pressure  waveform  as  calculated  by  the  Edwards  Lifesciences  
FloTracä.  The  FloTracä  is  a  pressure  transducer  that  transforms  the  arterial  pressure  
waveform  for  display  on  the  anesthesia  monitor,  but  more  importantly  the  FloTracä  calculates  
physiologically  relevant  features  of  the  waveform  that  clinicians  use  in  the  hemodynamic  
management  of  the  patient  such  as  stroke  volume,  stroke  volume  variation,  blood  pressure,  
systemic  vascular  resistance  etc.  There  are  also  other  more  complex  features  that  are  
calculated  but  not  currently  displayed  for  the  clinician  for  research  and  development  purposes.  
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These  include  spectral  features  of  the  waveform,  durations  between  different  peaks  and  
troughs  in  the  waveform,  areas,  slopes,  entropy,  variability,  etc.  In  addition  to  these  features,  
the  FloTracäalso  calculates  combinatorial  features,  nonlinear  and  linear  combinations  of  all  
features.  All  features  are  calculated  on  a  beat  to  beat  basis  and  then  averaged  over  20  seconds.  
A  beat  is  defined  by  the  systole  onset  to  end  of  diastole,  reflecting  the  contraction  and  
relaxation  of  the  heart  (Figure  7).  The  FloTracä  currently  calculates  ~2,600,000  features.  
  




The  302  patients  used  for  training  contained  25,461  positive  (for  hypotension)  
observations  and  56,143  negative  observations.  Observations  were  defined  as  instantaneous  20  
second  values  calculated  by  FloTracäat  a  positive  or  negative  time  point.  The  628  patients  used  
for  validation  contained  25,350  positive  observations  and  70,864  negative  observations.  The  





To  reduce  the  number  of  features  from  >2  million  to  a  more  reasonable  number,  first  
the  AUC  for  every  feature  was  calculated  and  the  features  with  an  AUC  >  0.85  were  selected.  
This  resulted  in  62  features.  Sequential  forward  feature  selection  with  logistic  regression  and  
ten-­‐fold  cross  validation  was  then  performed  on  those  features,  resulting  in  23  features.  
Sequential  forward  feature  selection  is  a  method  that  adds  features  one  by  one  to  a  logistic  
regression  model,  the  feature  that  improves  the  misclassification  rate  is  kept  until  some  
stopping  point  is  set  where  the  addition  of  another  feature  only  improves  the  misclassification  
rate  by  a  negligible  amount.  These  23  features  were  used  as  the  final  variables  for  a  logistic  
regression  model.  The  Hypotension  Probability  Index  (HPIÔ)  is  the  probability  outputted  by  the  
logistic  regression  model,  displayed  as  a  %  value.    
  
Model  Performance  Methods  
AUC  of  the  ROC  curve  was  used  to  evaluate  the  performance  of  the  model  on  the  
validation  set  to  choose  the  best  model.  The  best  model’s  performance  was  then  evaluated  on  
the  test  set  using  ROC  analysis  performance  as  well.  For  test  evaluation,  we  were  specifically  
interested  in  if  the  model  could  not  only  detect  the  start  of  an  event,  but  also  how  it  performed  
on  the  time  points  leading  up  to  the  start  of  an  event.  The  model  was  evaluated  on  the  time  
points  at  the  start  of  an  event  as  well  as  time  points  leading  up  to  an  event.  It  was  assumed  that  
these  time  points  should  indicate  positive  for  hypotension.  In  other  words,  0  minutes  to  event  
were  all  the  time  points  at  the  start  of  a  hypotensive  event.  X  minutes  to  event  were  all  the  
time  points  between  X  minutes  prior  to  the  event  and  start  of  event.  The  reason  for  this  is  that  
HPI  is  intended  to  be  an  indicator  for  not  only  the  detection  of  an  event  but  also  the  onset  of  
 58 
the  event.  In  other  words,  we  expected  that  HPI  should  increase  as  blood  pressure  starts  
heading  towards  a  hypotensive  event.  It  should  be  noted  that  all  events  are  100%  detected  by  




   HPI  performed  with  AUC  >  0.9  up  to  15  minutes  prior  the  start  of  a  hypotensive  event  
(Table  15).  
Table  15.  AUC  results  at  x  minutes  prior  to  start  of  a  hypotensive  event.  
Time  to  Start  
of  
Hypotensive  
Event  (min)   AUC  
0   1  
1   1  
2   0.998  
3   0.994  
4   0.99  
5   0.987  
10   0.973  
15   0.964  
  
In  addition,  we  see  qualitatively  that  HPI  works  as  intended,  trending  towards  100%  as  
MAP  approaches  a  hypotensive  event.  In  Figure  8,  we  can  see  that  HPI  is  greater  than  50%  
about  15  minutes  prior  to  the  start  of  an  event.  After  the  first  event  ended,  another  one  started  
about  10  minutes  after  and  HPI  remained  high.    
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Figure  8.  An  example  of  blood  pressure  decreasing  towards  a  hypotensive  event.  
 
Overall,  HPI  shows  great  performance  for  the  prediction  of  hypotensive  events  and  we  
expect  that  it  can  be  used  to  help  reduce  time  spent  in  hypotension  and  thus  improve  
postoperative  outcomes.    
  
PREDICTING  POST-­‐INDUCTION  HYPOTENSION  USING  THE  ARTERIAL  
BLOOD  PRESSURE  WAVEFORM  AND  EMR  
 
Intraoperative  hypotension  has  been  shown  to  be  associated  with  postoperative  
morbidity  and  mortality.22,49  One  time  period  of  specific  interest  is  the  time  following  induction  
of  anesthesia  and  prior  to  the  start  of  surgery,  aka  postinduction.  While  later  on  in  a  patient’s  
case  hemodynamic  changes  are  affected  by  surgical  stimulation  in  combination  with  general  
anesthesia,  postinduction  hypotension  can  uniquely  be  attributed  to  the  induction  event.  
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While  there  has  been  research  into  the  various  predictors  of  postinduction  hypotension,  
machine  learning  has  not  been  leveraged  until  recently  by  Kendale  et  al.  to  tackle  this  
problem.62–65  Utilizing  data  from  13,323  surgical  procedures,  Kendale  et  al.  compared  the  use  of  
logistic  regression,  support  vector  machines,  naïve  Bayes,  k  nearest  neighbor,  linear  
discriminant  analysis,  random  forest,  neural  networks,  and  gradient  boosting  machines  to  
predict  post  induction  hypotension.  The  overall  best  performing  model  type  was  gradient  
boosting  machine  with  an  AUC  of  0.74.  The  input  features  for  these  models  included  
demographics,  ASA,  medical  comorbidities,  preoperative  medications,  intraoperative  
medications,  intraoperative  medications,  surgical  start,  mean  peak  inspiratory  pressure,  and  
first  mean  arterial  pressure.  Kendale  et  al.’s  study  demonstrated  that  the  prediction  of  
postinduction  hypotension  was  feasible  using  machine  learning  and  readily  available  pre-­‐
induction  information.    
In  this  work,  we  aimed  to  expand  on  Kendale  et  al.’s  work  to  develop  a  deep  neural  
network  model  for  predicting  postinduction  hypotension  using  data  from  both  electronic  
medical  record  (EMR)  and  arterial  blood  pressure  (ABP)  waveform.  We  hypothesized  that  the  
use  of  more  complex  features  in  combination  with  a  well-­‐trained  complex  model  would  
improve  performance  of  the  classification.  
  
Data  Description  
All  data  for  this  study  was  collected  retrospectively  from  the  University  of  California,  





We  chose  to  replicate  the  features  used  by  Kendale  et  al.  in  the  prediction  of  
postinduction  hypotension65.  The  original  Kendale  et  al.  features  include  patient  comorbidities  
and  preoperative  medications  which  we  did  not  have  available  in  our  EMR  data  extraction.  
Thus,  we  included  only  the  following  subset  of  Kendale  et  al.’s  original  EMR  features:  age,  sex,  
body  mass  index  (BMI),  ASA  score,  intraoperative  medications,  mean  peak  inspiratory  pressure,  
first  mean  arterial  pressure  (MAP),  and  hour  of  surgery  start  time  (Table  16).  Sex  was  binary  
encoded  as  0  or  1  for  male  or  female,  respectively.  Intraoperative  medications  included  the  first  
administered  amounts  for  midazolam,  propofol,  etomidate,  fentanyl,  rocuronium,  and  
succinylcholine;  and  maximum  sevoflurane  concentration  and  desflurane  concentration  from  
case  start  to  10  minutes  from  induction  start.  Mean  peak  inspiratory  pressure  was  also  
extracted  from  the  same  time  window.  If  no  medication  or  gas  was  administered,  the  value  was  
set  as  0.  All  medications  were  also  cleaned  for  uniform  units  (i.e.  all  fentanyl  was  converted  to  
mg).  Incorrect  “annotations”  for  medications  and  peak  inspiratory  pressure  were  identified  by  
values  outside  the  clinically  acceptable  range  and  set  to  either  the  minimum  or  maximum  
possible  (Table  16).  Prior  to  extracting  the  first  MAP  value,  MAP  values  outside  of  a  physiologic  
range  similar  to  Kendale  et  al.  (MAP  less  than  20  mmHg,  MAP  greater  than  200  mmHg,  or  pulse  
pressure  less  than  20  mmHg)  were  excluded,  and  then  the  first  MAP  was  extracted.  ASA  score  
was  treated  as  categorical  and  one  hot  encoded  (each  unique  ASA  score  2  to  6  was  binary  
encoded  as  its  own  categorical  feature),  with  the  emergency  annotation  excluded.  In  addition  
to  the  Kendale  et  al.  features,  we  also  included  maximum,  minimum,  and  mean  heart  rate  (HR),  
MAP,  and  pulse  oximetry  (SpO2)  values,  resulting  in  28  EMR  features  total.  
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Table  16.  Description  of  model  input  features.  
  
*These  features  were  replicated  from  Kendale  et  al.  
  
Arterial  Blood  Pressure  (ABP)  Waveform  Processing  and  Feature  Extraction  
All  available  ABP  waveforms  from  5  minutes  prior  to  induction  up  to  induction  were  
extracted  and  resampled  to  100  Hz  for  uniformity.  The  waveform  was  then  split  into  20  second  
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windows,  and  processed  for  beat  detection,  beat-­‐to-­‐beat  features  and  beat  signal  quality  index  
(SQI)  using  algorithms  provided  by  the  blood  pressure  waveform  analysis  tools  in  the  PhysioNet  
Cardiovascular  Signal  Toolbox  (Figure  9).66  8  beat-­‐to-­‐beat  waveform  features  were  calculated:  
systolic  blood  pressure  (SBP),  diastolic  blood  pressure  (DBP),  pulse  pressure  (PP),  mean  arterial  
pressure  (MAP),  mean  of  all  negative  slopes  (noise;  dyneg),  beat  period,  heart  rate,  and  area  
under  systole.  SQI  is  binary,  and  any  beats  considered  “bad”  were  excluded  from  analysis.  The  
mean  of  all  features’  “good”  values  were  then  taken  as  input  features  into  the  model.  
  
  





Induction  was  defined  as  the  first  time  between  the  EMR  recorded  induction  event,  
propofol  administration,  and  etomidate  administration.  We  chose  this  definition  rather  than  
just  the  induction  event  time  recorded  in  the  EMR  to  avoid  inaccurate  labeling  caused  by  
 64 
potential  delays  in  clinician  annotations.  We  extracted  “clean”  beat-­‐to-­‐beat  MAP  values  from  
the  ABP  waveform  as  described  above  in  waveform  processing,  and  then  calculated  the  median  
MAP  preinduction  and  the  median  MAP  0  to  5  minutes  and  5  to  10  minutes  post  induction.64  
We  chose  to  define  hypotension  from  the  MAP  extracted  from  the  ABP  waveform  rather  than  
the  EMR  data  to  control  for  signal  quality  of  the  MAP  values  for  labeling  as  well  as  to  ensure  
time  synchronization.  In  addition,  rather  than  the  original  Kendale  et  al.  definition  of  any  MAP  
less  than  55  mmHg  within  10  minutes  of  induction,  we  chose  the  Reich  et  al.  definition  as  it  
includes  two  time  periods  for  the  label  prediction  and  is  more  robust  to  single  value  outliers.  
Postinduction  hypotension  was  defined  as  during  0  to  5  or  5  to  10  minutes  post  induction:  1)  
postinduction  MAP  decrease  of  >  40%  from  preinduction  and  postinduction  MAP  <  70  mmHg  or  
2)  postinduction  MAP  <  60  mmHg  
  
Model  Development  
In  this  work,  we  were  interested  in  predicting  2  labels:  hypotension  within  0  to  5  
minutes  and  within  5  to  10  minutes  postinduction  using  deep  neural  networks  (DNN),  aka  deep  
learning.  We  utilized  feed  forward  networks  with  fully  connected  layers  and  a  logistic  output  to  
output  a  probability  of  hypotension  (0  to  1).  We  trained  all  models  with  the  Adam  optimizer67  
with  default  parameters  and  initial  learning  rates  (0.01,  0.1,  0.5),  and  a  batch  size  of  (32,  64,  
128).  The  learning  rate  was  reduced  by  a  factor  of  10  when  validation  loss  stopped  improving.    
We  also  assessed  DNN  architectures  of  1  to  5  hidden  layers  with  10  to  100  neurons  per  
layer,  with  hyperbolic  tangent  (tanh)  activation  functions.  To  reduce  overfitting,  we  utilized  
early  stopping  with  a  patience  of  10  epochs,  L2  weight  regularization  (0.001,  0.0001)  and  
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dropout  46,50(0,  0.25,  0.5).  The  loss  function  was  cross  entropy.  We  trained  two  separate  
models,  one  for  each  label.  Due  to  the  limited  number  of  patients  available  for  training,  we  
utilized  leave  one  out  (LOO)  cross  validation.  For  each  iteration  of  LOO,  1  patient  was  held  out  
from  training  for  validation  and  the  other  223  were  split  into  80%  for  training  and  20%  for  
“training-­‐validation”  to  track  loss  to  avoid  overfitting.  The  model  results  reported  here  are  for  
the  models  with  the  best  LOO  validation  performance.  We  also  trained  models  with  different  
input  feature  sets:  1)  ABP  waveform  features  (n=8),  2)  EMR  features  (n=28)  and  3)  both  
waveform  and  EMR  features  (n=36).    
  
Model  Performance  Methods  
For  comparison,  we  looked  at  logistic  regression  (LR)  with  the  same  feature  sets.  For  all  
performance  results,  we  took  each  leave  one  out  validation  result  and  pooled  them  together  to  
calculate  area  under  the  receiver  operating  characteristic  curve  (AUC)  and  average  precision  
(AP).  Sensitivity,  specificity,  precision,  and  F1  scores  were  calculated  for  thresholds  chosen  by  
highest  F1  score  for  each  model.  95%  confidence  intervals  were  calculated  with  bootstrapping.  
We  assessed  feature  importance  in  the  DNN  models  with  feature  ablation  analysis.  After  
finalizing  the  model  architectures,  we  removed  each  feature,  performed  leave  one  out  training  
and  validation,  and  assessed  the  decrease  in  AUC  for  the  validation  data.  To  assess  which  
features  are  the  most  predictive  in  the  logistic  regression  model.  We  calculated  the  mean  
weights  for  each  feature  following  leave  one  out  training.  
All  deep  neural  network  models  were  developed  using  Keras68.  Logistic  regression  models  and  




There  was  a  total  of  19,545  surgical  patients  from  November  2015  to  August  2017,  of  
which  1,120  patients  had  arterial  blood  pressure  (ABP)  waveform  data  prior  to  induction.  After  
waveform  preprocessing  for  signal  quality,  there  were  224  patients  included  in  the  model  
development.  The  significant  decrease  in  patient  numbers  from  those  with  ABP  waveforms  to  
those  with  “good”  signal  quality  is  due  to  the  presence  of  a  signal  even  if  there  is  no  arterial  line  
connected  to  the  monitor.  As  long  as  an  arterial  line  transducer  is  connected  to  the  patient  
monitor,  an  ABP  signal  is  collected.  The  transducer  is  usually  set  up  prior  to  arterial  line  
placement,  and  thus  noise  is  collected  until  the  arterial  line  is  placed  and  zeroed.  Preprocessing  
the  waveform  for  signal  quality  was  essential  to  exclude  noisy  data.  Of  the  224  patients,  22  
patients  (9.8%)  had  postinduction  hypotension  within  0  to  5  minutes  and  20  patients  (8.9%)  
had  postinduction  hypotension  within  5  to  10  minutes.  Patient  demographics  are  described  in  
Table  17.  
The  final  deep  neural  network  parameters  for  each  DNN  model  and  feature  set  
combination  are  described  in  Table  18.  All  performance  metrics  reported  below  refer  to  the  

















Table  18.  Final  model  hyperparameters  for  each  DNN  model  and  feature  combination  for  predicting  
hypotension  0  to  5  minutes  or  5  to  10  minutes  postinduction  
  
Model  Performance  
Area  under  the  receiver  operating  characteristic  curve  (AUC  ROC)  and  average  precision  
(AP)  are  summarized  in  Table  19.  All  DNN  models  had  higher  AUCs  than  logistic  regression  (LR)  
for  each  feature  set,  except  for  the  EMR  only  features  model  to  predict  5  to  10  minutes  post  
induction  hypotension  (DNN  AUC  0.63  (0.497  –  0.76);  AP  0.143  (0.084  –  0.266)  vs  LR  AUC  0.667  
(0.555  –  0.78);  AP  0.151  (0.089  –  0.284)).  The  best  performing  model  for  predicting  0  to  5  
minutes  post  induction  hypotension  was  DNN  with  waveform  only  features  (AUC  0.88  (0.812-­‐
0.934);  AP  0.391  (0.241  –  0.631),  followed  by  LR  with  waveform  only  features  (AUC  0.875  (0.81-­‐
0.929);  AP  0.372  (0.224  –  0.598)).  The  best  performing  model  for  predicting  5  to  10  minutes  
postinduction  was  DNN  with  waveform  only  features  (AUC  0.703  (0.557-­‐0.823);  AP  0.228  (0.115  
–  0.433)),  followed  by  LR  with  EMR  only  features  (AUC  0.667  (0.555-­‐0.78);  AP  0.176  (0.089  –  
0.345)).  When  assessing  the  different  feature  sets,  the  use  of  waveform  only  features  
performed  best  overall,  and  EMR  only  features  performed  the  worst,  except  in  predicting  5  to  





Table  19.  AUC  and  AP  with  95%  CIs  for  the  DNN  and  LR  models  for  prediction  of  postinduction  
hypotension.  
  
We  used  the  highest  F1  score  to  choose  a  threshold  for  all  models,  as  it  balances  
sensitivity  and  specificity.  When  predicting  0  to  5  minutes  postinduction  hypotension,  the  DNN  
model  with  waveform  features  had  the  highest  F1  score  (0.537  (0.324-­‐0.706),  followed  by  the  
LR  model  with  waveform  features  (0.5  (0.279-­‐0.667)).  The  DNN  model  with  waveform  features  
had  a  higher  specificity  than  the  LR  model  (0.96  (0.931-­‐0.985)  vs  0.946  (0.912-­‐0.975)),  and  
equivalent  sensitivity  (0.5  (0.286-­‐0.714)  vs  0.5  (0.278-­‐0.714)).  When  predicting  5  to  10  minutes  
postinduction  hypotension,  the  DNN  model  with  waveform  features  had  the  highest  F1  score  
(0.364  (0.158-­‐0.533)),  followed  by  the  LR  model  with  waveform  features  (0.312  (0.08-­‐0.513)).  
The  DNN  model  had  higher  sensitivity  than  the  LR  model  (0.4  (0.176-­‐0.625)  vs  0.25  (0.059-­‐
0.444)),  but  lower  specificity  (0.922  (0.884-­‐0.956)  vs  0.966  (0.939-­‐0.99)).  
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Feature  Importance  
Although  the  models  trained  with  the  waveform  and  EMR  feature  sets  were  not  the  
best  performing  model,  we  wanted  to  compare  not  only  the  difference  in  feature  importance  
across  model  types  (DNN  vs  LR)  but  also  how  each  model  looked  at  the  EMR  vs  waveform  
features.  We  assessed  the  results  of  feature  ablation  for  the  DNN  trained  with  EMR  and  
waveform  features  and  the  LR  model  weights  for  the  same  feature  set.    
  




Figure  11.  Logistic  regression  models  coefficients  
The  top  five  DNN  features  for  the  0  to  5  minutes  postinduction  hypotension  model  were  
the  mean  beat  period  (waveform),  mean  systolic  area  (waveform),  mean  heart  rate  
(waveform),  max  heart  rate  (EMR),  and  surgery  start  (EMR;  Kendale  et  al.)  (Figure  11).    The  top  
five  logistic  regression  features  were  mean  MAP  (waveform),  ASA  4  (EMR;  Kendale  et  al.),  mean  
pulse  pressure  (waveform),  ASA  3  (EMR;  Kendale  et  al.),  and  beat  period  (waveform)  (Figure  
12).  Overall,  three  of  the  top  five  features  in  both  the  DNN  and  logistic  regression  models  were  
waveform  features.    
The  top  five  deep  neural  network  features  for  the  5  to  10  minutes  postinduction  
hypotension  model  were  ASA  4  (EMR;  Kendale  et  al.),  maximum  desflurane  (EMR;  Kendale  et  
al.),  maximum  MAP  from  cuff  (EMR),  mean  MAP  (waveform),  and  mean  pulse  pressure  
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(waveform).  The  top  five  logistic  regression  features  were  minimum  heart  rate  (EMR),  ASA  5  
(EMR;  Kendale  et  al.),  surgery  start  (EMR;  Kendale  et  al.),  ASA  4  (EMR;  Kendale  et  al.),  and  ASA  
2  (EMR;  Kendale  et  al.).  Both  the  DNN  and  logistic  regression  models  had  ASA  4  as  a  top  
feature,  however,  the  logistic  regression  model  had  no  waveform  features  in  either  the  top  five  
or  the  top  ten  features.  In  addition,  this  logistic  regression  model  performed  the  worst  of  the  5  
to  10  minutes  postinduction  hypotension  models.  
  
AN  INTERPRETABLE  NEURAL  NETWORK  FOR  PREDICTING  
POSTOPERATIVE  IN-­‐HOSPITAL  MORTALITY  
 
We  recently  showed  that  deep  neural  networks  (DNNs)  using  only  readily  available  
intraoperative  information  extracted  from  the  electronic  health  record  can  successfully  predict  
postoperative  in-­‐hospital  mortality  with  an  AUC  of  0.91.44  While  DNNs  are  great  machine  
learning  models  and  often  have  higher  accuracy  than  more  simple  models  like  logistic  
regression,  they  are  often  thought  of  as  a  “black  box”  and  not  interpretable.  In  healthcare,  
intelligible  models  not  only  help  clinicians  to  understand  the  problem  and  create  more  targeted  
action  plans,  they  also  help  to  gain  the  clinicians’  trust.  Thus,  logistic  regression  models  remain  
popular  in  the  healthcare  space,  as  they  are  robust,  easy  to  implement  and  usually  have  good  
performance,  as  we  have  also  seen  in  our  previous  work  comparing  DNNs  to  logistic  
regression.44  However,  logistic  regression  is  limited  by  the  fact  that  it  can  only  model  a  linear  
relationship  between  the  input  features  and  its  target  response,  which  may  not  only  be  
misleading  but  also  not  clinically  intuitive.  For  example,  both  hypervolemia  and  hypovolemia  
have  been  shown  to  increase  the  risk  of  postoperative  complications,  reflecting  a  nonlinear  
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relationship  between  a  patient’s  volume  status  and  the  risk  for  complications69.  While  DNNs  are  
capable  of  learning  nonlinear  relationships,  they  lack  the  interpretability  of  logistic  regression.    
One  method  of  overcoming  the  limitations  of  a  linear  model  such  as  logistic  regression  is  
through  generalized  additive  models  (GAMs).  Caruana  et  al.  demonstrated  GAMs  could  be  
applied  to  real  healthcare  problems  such  as  pneumonia  risk  with  high  accuracy.70  Through  a  
graphical  representation  of  each  model  feature’s  learned  contribution  to  the  predicted  risk,  the  
interpretable  GAMs  help  to  visualize  learned  patterns  and  identify  new  patterns  in  the  data  or  
confirm  what  clinicians  already  know.  Inspired  by  GAMs,  the  same  idea  can  be  applied  to  neural  
networks  through  an  architecture  referred  to  as  Generalized  Additive  Neural  Networks  
(GANNs).71  Bras-­‐Geraldes  et  al.  showed  GANNs  could  be  used  to  predict  mortality  in  the  ICU  
with  an  AUC  of  0.83,  using  19  features  from  vital  signs,  lab  values,  demographics,  admission  
information,  and  comorbidities.72  
Models  like  DNNs  allow  for  learning  the  more  complex  relationship  between  the  input  
and  class  label,  however,  they  are  not  as  easily  interpretable  as  logistic  regression.  In  this  work,  
we  applied  the  same  idea  of  the  Generalized  Additive  Neural  Networks  architecture  to  allow  for  





All  data  used  in  this  study  came  from  the  UCLA  Medical  Center  described  previously.  
The  original  87  features  from  this  data  set  were  reduced  to  45  features  in  our  previous  work,  
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and  ASA  was  added  as  a  feature  in  the  final  model  (46  features)  that  improved  model  
performance.44  In  this  study,  we  used  the  same  features,  but  also  added  previously  not  
included  features:  total  anesthesia  case  time  (1  feature);  the  time  spent  with  MAP  below  40,  
45,  50,  55,  60,  and  65  mmHg  (6  features);  and  HCUP  Code  Descriptions  of  the  Primary  CPT  
codes  (33  features).  There  were  183  unique  HCUP  Code  Descriptions  in  our  data  set,  and  we  
selected  33  HCUP  Code  Descriptions  that  were  present  in  at  least  1  percent  of  the  total  data  
(Appendix  B).  These  HCUP  Code  Descriptions  were  then  encoded  as  33  binary  features.    
Data  Preprocessing  
  
Before  model  development,  missing  values  for  ASA  scores  were  filled  with  the  most  
common  value  (ASA  3);  missing  values  for  medications  administration  features  were  filled  with  
0;  and  all  other  missing  values  were  filled  with  the  means  for  that  feature.  Values  that  were  
greater  than  a  clinically  normal  maximum  (determined  by  M.C.  and  I.H.)  were  set  to  a  maximum  
possible,  as  described  in  previous  work.44  Finally,  all  training  data  were  rescaled  to  have  mean  0  




In  this  work,  we  were  interested  in  classifying  patients  at  risk  of  in-­‐hospital  mortality  




Figure  12.  Proposed  generalized  additive  neural  network  (GANN)  architecture  and  description  of  feature  
contributions  calculation,  for  n  individual  continuous  features  vs  binary  features  
  
All  data  was  randomly  split  into  80%  for  training  (n=  47,988)  and  20%  for  test  (n=11,997)  
prior  to  model  development.  All  GANNs  were  trained  on  80%  of  the  data  with  5-­‐fold  cross  
validation  to  optimize  hyperparameters.  All  models  were  trained  with  a  batch  size  of  256  and  
Adam  optimization67  with  default  parameters  and  reduced  the  learning  rate  by  a  factor  of  10  
when  the  validation  loss  stopped  improving  for  a  patience  of  5  epochs,  a  batch  size  of  256,  and  
a  maximum  of  100  epochs.  Dropout  (0.25,  0.5,  0.9)46,50,  L2  regularization  (0.001,  0.0001)  and  
early  stopping  with  a  patience  of  5  epochs  were  used  to  prevent  overfitting.  In  our  GANN  
architecture,  each  feature  had  its  own  network  of  hidden  layers  (1,  4)  with  (10,  40  to  50,  90,  
100)  neurons  with  (rectified  linear  unit  (ReLu),  hyperbolic  tangent  (tanh))  activations  (Figure  
13).  These  hidden  layers  are  followed  by  a  last  layer  with  just  1  neuron  with  a  tanh  activation.  
This  last  tanh  layer  transforms  the  previous  layer’s  output  into  one  value  and  forces  the  
feature’s  neural  network  final  output  to  be  between  -­‐1  and  1.  The  outputs  of  all  the  features’  
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tanh  layers  are  then  concatenated  prior  to  being  input  into  a  logistic  layer.  The  feature  
contributions  are  calculated  as  their  tanh  layer  outputs  multiplied  by  their  respective  logistic  
weights.  Binary  features  only  had  a  direct  connection  from  input  to  the  logistic  layer,  and  so  
their  feature  contributions  are  calculated  as  the  input  value  multiplied  by  their  respective  
logistic  weights.  
  
Model  Performance  Methods  
Model  performance  was  assessed  using  area  under  the  receiver  operating  characteristic  
curve  (AUC)  and  average  precision  (AP).  All  results  reported  were  calculated  on  the  test  set  and  
95%  confidence  intervals  were  calculated  using  bootstrapping  with  1,000  samples.  The  same  
training  and  test  sets  were  used  in  this  work  as  our  previous  work  on  in-­‐hospital  mortality  for  
comparison.44  In  addition,  as  HCUP  codes  are  not  immediately  available  at  the  end  of  surgery,  
we  assessed  model  performance  for  models  developed  with  and  without  HCUP  features.  
All  neural  network  models  were  developed  using  Keras.68  Logistic  regression  models  and  
performance  metrics  were  calculated  with  scikit-­‐learn.48  
  
Results  
The  data  consisted  of  59,985  surgical  records,  and  the  %  occurrence  of  in-­‐hospital  
mortality  was  0.81%  (n=389)  in  the  training  set  and  0.72%  (n=87)  in  the  test  set.  The  final  
hyperparameters  for  each  GANN  model  and  feature  set  combination  are  described  in  Table  20.    
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All  performance  metrics  reported  below  refer  to  the  test  set  (n=11,997).  Area  under  the  
receiver  operating  characteristic  curve  (AUC  ROC)  and  average  precision  (AP)  are  summarized  in  
Table  21.  The  GANN  model  with  HCUP  features  had  the  highest  AUC  0.921  (0.895-­‐0.95).  Overall,  
both  GANN  models  had  higher  AUCs  than  LR  models,  however  had  lower  APs.  The  LR  model  
without  HCUP  features  had  the  highest  AP  0.217  (0.136-­‐0.31).  
Table  21.  AUC  results  of  GANN  and  LR  models  with  and  without  HCUP  features  
  
Interpretability  
To  assess  the  interpretability  of  the  GANNs,  we  visualized  the  learned  contributions  of  
the  GANNs  vs  the  learned  contributions  of  the  LRs  for  the  models  with  HCUP  features.  As  
described  in  the  methods,  the  learned  contribution  of  the  GANNs  for  each  feature  is  its  last  
tanh  layer’s  output  multiplied  by  its  respective  weight  from  the  logistic  layer.  Since  the  binary  
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features  have  a  direct  connection  from  input  to  the  logistic  layer,  the  binary  features’  learned  
contributions  would  be  their  input  values  multiplied  by  their  respective  weight  from  the  logistic  
layer.  The  learned  contribution  of  the  LR  model  is  the  input  value  multiplied  by  its  respective  
weight  from  the  LR  model.  
In  Figure  14,  we  visualize  these  contributions  and  selected  a  sample  of  the  top  9  
contributing  features  in  the  GANN  model.  The  top  9  were  chosen  by  selecting  the  features  with  
the  highest  mean  GANN  contribution.  We  did  not  include  any  binary  features  in  this  example,  
such  as  presence  of  arterial  line,  as  their  visualization  would  not  be  as  interested,  since  there  
would  only  be  2  values  to  plot.  We  see  that  overall  the  direction  of  the  learned  contributions  
from  both  the  GANN  and  LR  models  were  similar,  i.e.  as  MAX_DES  increases  the  contributions  
for  both  models  decreased.  However,  while  the  LR  model  will  always  have  a  linear  relationship,  
the  GANN  learned  non-­‐linear  relationships  that  were  unique  to  each  feature.  For  example,  for  
the  feature  AVG_MAP_10_MIN  we  see  a  non-­‐linear  function  where  GANN  contributions  
increase  for  MAP  <  60  mmHg  and  for  MAP  >  60  mmHg.  One  odd  relationship  is  the  one  
observed  between  ANES_CASE_HOURS  and  mortality  risk,  where  with  less  hours  spent  under  
anesthesia  there  was  more  contribution  to  mortality  risk.  This  could  be  a  reflection  of  the  
infrequency  of  extremely  high  anesthesia  case  hours  (>  10  hours),  and  that  in-­‐hospital  mortality  
patients  may  not  spend  significantly  longer  amounts  of  time  under  anesthesia  compared  to  
non-­‐mortality  patients.  In  addition,  while  risk  contribution  increased  with  lower  MIN_DBP,  
there  was  the  opposite  relationship  for  AVG_DBP_10_MIN  and  AVG_DBP,  which  could  indicate  
that  not  all  summary  measures  of  vital  signs  are  the  same,  and  that  these  should  be  taken  into  
















Figure  13.  Sample  of  9  continuous  features  that  had  the  highest  mean  mortality  risk  GANN  contributions  
across  all  patients,  in  order  of  highest  to  lowest  (left  to  right,  top  to  bottom).  
The  feature’s  values  for  all  patients  are  plotted  on  the  x  axis  and  the  respective  GANN  contribution  (blue)  on  the  
primary  y  axis  and  LR  contribution  (green)  on  the  secondary  y  axis.  The  more  negative  the  risk  contribution,  the  less  
contribution  the  respective  value  has  to  the  risk  of  mortality.  
  
In  our  interpretable  model,  we  can  also  look  at  the  top  contributors  to  a  risk  of  mortality  
(Table  22).  If  we  look  at  the  top  10  GANN  contributions  from  the  best  performing  GANN  with  
HCUP  features  for  2  unique  in-­‐hospital  mortality  patients  from  the  test  set,  we  can  see  that  the  
features  that  contributed  most  were  different.  For  example,  a  high  ASA  score  of  4  contributed  
highly  for  Patient  Example  1,  bud  did  not  show  up  as  a  top  contributor  for  Patient  Example  2.    
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Table  22.  Top  10  neural  network  contributions  learned  from  the  best  performing  GANN  model  with  HCUP  
features,  for  2  in-­‐hospital  mortality  patient  examples  from  the  test  set.  
  
  
CONCLUSIONS  AND  RECOMMENDED  FUTURE  WORK  
Modern  medicine  requires  tools  to  change  from  “reactive”  patient  management  to  a  
more  “prospective”  or  “proactive”  approach.  However,  these  tools  need  to  not  only  be  
accurate,  but  also  interpretable  and  therefore  actionable  by  the  clinician.  There  are  2  ways  to  
approach  prospective  healthcare:  1)  A  one-­‐time  risk  classification  to  help  allocate  hospital  
resources  more  efficiently  to  ensure  patients  receive  necessary  critical  care  and  2)  A  
continuous,  real  time  risk  classification  to  avoid  onset  of  complications  altogether.  
Throughout  this  thesis,  I  have  shown  the  deep  neural  networks  can  perform  with  high  
accuracy  when  compared  to  currently  used  common  risk  scores  for  adverse  outcomes,  such  as  
AKI,  reintubation,  and  mortality.  We  were  also  able  to  develop  models  for  predicting  acute  
intraoperative  events,  such  as  hypotension,  that  can  increase  the  risk  of  those  same  adverse  
outcomes.  In  addition,  while  logistic  regression  performed  comparably  for  many  of  the  
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problems,  we  have  also  shown  its  limitations.  Logistic  regression  is  often  preferred  in  the  
medical  field  due  to  its  easy  implementation  and  interpretability.  However,  it  can  only  impose  
linear  relationships  between  features  and  response  labels,  such  as  the  risk  of  in-­‐hospital  
mortality.  One  of  the  drawbacks  of  deep  neural  networks  has  been  its  “black  box”  reputation.  
In  response,  we  proposed  a  generalized  additive  neural  network  (GANN)  architecture  to  learn  
nonlinear  patterns  in  the  data  that  resembled  more  of  clinical  intuition  and  can  be  interpreted  
easily.  With  these  GANNS,  we  were  able  to  show  that  we  can  automatically  learn  clinically  
intuitive  relationships  without  domain  knowledge  or  extra  featurization,  give  clinicians  
interpretability,  and  maintain  model  performance.  
While  one-­‐time  risk  classifications  are  useful,  clinicians  need  continuous  indicators  for  
managing  patients  in  a  real-­‐time,  acute  setting.  We  made  a  first  attempt  at  this  by  developing  a  
Hypotension  Prediction  Index  (HPIä),  which  predicts  the  probability  of  future  onset  of  
hypotension  using  features  from  the  arterial  blood  pressure  waveform.  HPIä  is  currently  FDA-­‐
approved  and  a  commercial  product  (Edwards  Lifesciences,  Irvine,  CA).  
Future  work  would  include  leveraging  the  >19,000  surgical  patients  worth  of  data  we  
have  collected  from  the  UCI  Medical  Center  and  prepared  for  research-­‐use.  Much  of  the  initial  
years  of  my  research  were  spent  on  gathering,  cleaning,  and  understanding  this  data  set.  While  
we  were  able  to  successfully  unify  EMR  and  arterial  blood  pressure  waveform  data  to  predict  
postinduction  hypotension  using  deep  neural  networks  with  this  dataset,  we  were  severely  
limited  by  the  number  of  includable  patients  and  thus  did  not  get  good  results  with  more  
complex  models  such  as  convolutional  neural  networks  that  would  require  more  data.  Next  
steps  would  be  to  use  more  frequently  available  inputs,  such  as  HR,  SpO2,  and  blood  pressure  
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cuff  measurements  that  are  available  for  all  patients,  in  models  like  LSTMs  which  would  
incorporate  time.  There  is  also  much  to  be  learned  from  the  waveforms  we  have  collected.  
Instability  and  subsequent  shock  are  very  complicated  physiologically,  and  thus  may  require  a  
more  complex  input  that  is  not  captured  in  the  static  features  like  HR  and  BP  which  are  
extracted  from  the  waveform  to  begin  with.  Future  work  could  also  include  utilizing  
unsupervised  learning  on  the  waveforms  to  determine  periods  of  unique  hemodynamic  
patterns,  and  see  if  those  correlate  to  what  is  occurring  or  will  occur  in  the  patient.  Supervised  
learning  could  also  be  used  if  a  definition  for  shock  can  be  extracted  from  the  EMR.  
This  thesis  work  can  be  summarized  as  follows:  by  utilizing  readily  available  patient  
monitoring  data,  we  can  build  predictive  models  to  help  inform  clinicians  in  the  management  of  
their  patients  as  well  as  help  them  avoid  poor  outcomes  or  acute  events.  These  models  need  to  
be  easily  implementable,  interpretable,  and  accurate.  Once  trained,  most  models,  even  ones  
large  and  complex  as  a  deep  neural  network,  are  easily  implementable.  The  models  created  
throughout  this  thesis  were  developed  initially  with  only  the  classic  approach  of  just  meeting  
the  accuracy  need.  However,  we  then  shifted  our  approach  to  develop  for  interpretability  in  
addition  to  accuracy.  Next  steps  would  be  to  leverage  the  large  UCIMC  dataset  we  have  created  
to  continue  to  develop  more  interpretable  models  that  can  also  be  displayed  continuously,  in  
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Appendix  A.  Description  of  liver  transplant  features  
  





keep  feature  in  
reduced  feature  set  
abo_A   if  type  A,  A1,  or  A2   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
abo_AB   if  type  AB,  A1B,  or  A2B   Y   [0.0,  1.0]   keep  
abo_B   if  type  B   Y   [0.0,  1.0]   keep  
abo_don_A   see  above   Y   [0.0,  1.0]   keep  
abo_don_AB   see  above   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
abo_don_B   see  above   Y   [0.0,  1.0]   keep  
 89 
abo_don_O   if  type  O   Y   [1.0,  0.0]   keep  
abo_mat      Y   [1.0,  2.0,  3.0]   keep  
abo_O   if  type  O   Y   [1.0,  0.0]   keep  
age      N      keep  
age_don      N      keep  
albumin_tx      N      keep  
antihype_don      Y   [1.0,  0.0,  nan]   keep  
arginine_don      Y   [1.0,  0.0,  nan]   keep  
ascites_tx      N      keep  
bact_perit_tcr      Y   [0.0,  nan,  1.0]   keep  
bmi_calc      N      keep  
bmi_don_calc      N      keep  
bmi_tcr      N      keep  
bun_don      N      keep  
cardarrest_neuro      Y   [0.0,  1.0,  nan]   keep  
cdc_risk_hiv_don      Y   [0.0,  1.0,  nan]   keep  
citizenship  
if  not  equal  to  1,  set  to  1;  
otherwise,  0   Y   [0.0,  1.0]  




Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
clin_infect_don      Y   [1.0,  0.0,  nan]   keep  
cmv_don      Y   [0.0,  1.0,  nan]   keep  
cmv_igg      Y   [1.0,  0.0,  nan]   keep  
cmv_igm  
  
Y   [nan,  0.0,  1.0]  
remove  due  to  >50  
percent  null  
cmv_status      Y   [1.0,  0.0,  nan]   keep  
cod_cad_don_1  
if  cod_cad_don  ==  1,  set  to  
1   Y   [1.0,  0.0]   keep  
cod_cad_don_2  
if  cod_cad_don  ==  2,  set  to  
1   Y   [0.0,  1.0]   keep  
cod_cad_don_3  
if  cod_cad_don  ==  3,  set  to  
1   Y   [0.0,  1.0]   keep  
cod_cad_don_4  
if  cod_cad_don  ==  4,  set  to  
1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  




n"  equals  0  and  
"coronoary_angio_don"  
equals  1,  set  to  1;  if  
"coronary_angio_norm_do
n"  equals  1  and  
"coronoary_angio_don"  
equals  1,  set  to  2;   Y   [0.0,  2.0,  1.0]   keep  
creat_don      N      keep  
creat_tx      N      keep  
 90 
dayswait_chron      N      keep  
ddavp_don      Y   [0.0,  1.0,  nan]   keep  
death_circum_don   if  not  equal  to  6,  set  to  1   Y   [1.0,  0.0]   keep  
death_mech_don   if  equal  to  12,  set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn_tcr_AHN  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn_tcr_autoimmune  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn_tcr_cryptogenic  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]   keep  
dgn_tcr_etoh  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]   keep  
dgn_tcr_etoh_hcv  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]   keep  
dgn_tcr_HBV  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn_tcr_HCC  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]   keep  
dgn_tcr_HCV  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]   keep  
dgn_tcr_NASH  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]   keep  
dgn_tcr_PBC  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn_tcr_PSC  
see  diag_*  description;  
except  looking  at  "dgn_tcr"   Y   [1.0,  0.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_AHN  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_autoimmune  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_cryptogenic  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_etoh  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_etoh_hcv  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  




see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_HCC  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]   keep  
dgn2_tcr_HCV  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_NASH  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_PBC  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
dgn2_tcr_PSC  
see  diag_*  description;  
except  looking  at  
"dgn2_tcr"   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diab  
if  not  equal  to  1,  set  to  1;  
otherwise,  0   Y   [0.0,  1.0]   keep  
diabdur_don      N      keep  
diabetes_don      Y   [0.0,  1.0,  nan]   keep  
diag_AHN  
if  "diag"  is  in  [4100,  4101,  
4102,  4103,  4104,  4105,  
4106,  4107,  4108,  4110,  
4217],  set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diag_autoimmune  
if  "diag"  is  in  [4212],  set  to  
1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diag_cryptogenic  
if  "diag"  is  in  [4213,  4208],  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diag_etoh  
if  "diag"  is  in  [4215],  set  to  
1   Y   [0.0,  1.0]   keep  
diag_etoh_hcv  
if  "diag"  is  in  [4216],  set  to  
1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diag_HBV  
if  "diag"  is  in  [4202,  4592],  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diag_HCC  
if  "diag"  is  in  [4400,  4401,  
4402],  set  to  1   Y   [0.0,  1.0]   keep  
diag_HCV  
if  "diag"  is  in  [4204,  4593],  
set  to  1   Y   [0.0,  1.0]   keep  
diag_NASH  
if  "diag"  is  in  [4214],  set  to  
1   Y   [0.0,  1.0]   keep  
diag_PBC  
if  "diag"  is  in  [4220],  set  to  
1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
diag_PSC  
if  "diag"  is  in  [4240,  4241,  
4242,  4245],  set  to  1   Y   [1.0,  0.0]  
remove  due  to  >95  
percent  zero  
dial_tx      Y   [0.0,  1.0,  nan]   keep  
distance      N      keep  




Y   [0.0,  nan,  1.0]  
remove  due  to  >95  
percent  zero  
ebv_serostatus      Y   [1.0,  0.0,  nan]   keep  
ecd_donor      Y   [0.0,  1.0]   keep  
education      N      keep  
enceph_tx      N      keep  
end_stat  
if  equal  to  6010  or  6011,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
ethcat_1   if  "ethcat"  =  1   Y   [0.0,  1.0]   keep  
ethcat_2   if  "ethcat"  =  2   Y   [1.0,  0.0]   keep  
ethcat_4   if  "ethcat"  =  4   Y   [0.0,  1.0]   keep  
ethcat_5   if  "ethcat"  =  5   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
ethcat_don_1   see  above   Y   [1.0,  0.0]   keep  
ethcat_don_2   see  above   Y   [0.0,  1.0]   keep  
ethcat_don_4   see  above   Y   [0.0,  1.0]   keep  
ethcat_don_5   see  above   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
ethcat_don_other  
if  "ethcat_don"  >=  6,  set  to  
1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
ethcat_other   if  "ethcat"  >=  6,  set  to  1   Y   [0.0,  1.0]  




Y   [nan,  1.0,  0.0]  
remove  due  to  >50  
percent  null  
exc_case      Y   [0.0,  1.0]   keep  
exc_diag_id_cat1  
if  "exc_diag_id"  equals  1,  
3,  or  10,  set  to  1   Y   [0.0,  1.0]   keep  
exc_diag_id_cat2  
if  "exc_diag_id"  equals  2,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
exc_diag_id_cat3  
if  "exc_diag_id"  equals  4,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
exc_diag_id_cat4  
if  "exc_diag_id"  equals  5,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
exc_diag_id_cat5  
if  "exc_diag_id"  equals  6  or  
12,  set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
exc_diag_id_cat6  
if  "exc_diag_id"  equals  11,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
exc_diag_id_cat7  
if  "exc_diag_id"  equals  9,  
set  to  1   Y   [0.0,  1.0]   keep  
exc_ever      Y   [0.0,  1.0]   keep  
exc_hcc   HCC  =  1,  non-­‐HCC  =  0   Y   [0.0,  1.0]   keep  
final_inr      N      keep  
final_serum_sodium      N      keep  
func_stat_tcr  
Replaced  [2,  2040,  2050,  
2060,  2070]  as  1;  Replaced  
[3,  2010,  2020,  2030]  as  2;  
otherwise  0  if  not  empty   N      keep  
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func_stat_trr  
Replaced  [2,  2040,  2050,  
2060,  2070]  as  1;  Replaced  
[3,  2010,  2020,  2030]  as  2;  
otherwise  0  if  not  empty   N      keep  
gender      Y   [0.0,  1.0]   keep  
gender_don      Y   [0.0,  1.0]   keep  
hbv_core      Y   [0.0,  1.0,  nan]   keep  
hbv_core_don      Y   [0.0,  1.0,  nan]   keep  
hbv_sur_antigen  
  
Y   [0.0,  1.0,  nan]  




Y   [0.0,  1.0,  nan]  




Y   [nan,  0.0,  1.0]  
remove  due  to  >50  
percent  null  
hcv_serostatus      Y   [0.0,  1.0,  nan]   keep  
hematocrit_don      N      keep  
hep_c_anti_don  
  
Y   [0.0,  1.0,  nan]  
remove  due  to  >95  
percent  zero  
heparin_don      Y   [1.0,  0.0,  nan]   keep  
hgt_cm_calc      N      keep  
hgt_cm_don_calc      N      keep  
hgt_cm_tcr      N      keep  
hist_cancer_don  
  
Y   [0.0,  1.0,  nan]  
remove  due  to  >95  
percent  zero  
hist_cig_don      Y   [1.0,  0.0,  nan]   keep  
hist_cocaine_don      Y   [1.0,  0.0,  nan]   keep  
hist_insulin_dep_don  
  
Y   [nan,  1.0,  0.0]  
remove  due  to  >50  
percent  null  
hist_oth_drug_don      Y   [1.0,  0.0,  nan]   keep  
history_mi_don  
  
Y   [0.0,  1.0,  nan]  




equals  0,  set  to  1   N      keep  
index2  
Created  by  Brent:  This  
variable  indicates  the  
number  of  liver  transplants  
the  patient  has  ever  had  
previously   N      keep  
init_age      N      keep  
init_albumin      N      keep  
init_ascites      N      keep  
init_bilirubin      N      keep  
init_bmi_calc      N      keep  
init_dialysis_prior_week  
  
Y   [nan,  0.0,  1.0]  
remove  due  to  >95  
percent  zero  
init_enceph   replaced  4  with  null   N      keep  
 94 
init_hgt_cm      N      keep  




N      keep  
init_serum_creat      N      keep  
init_serum_sodium      N      keep  
init_stat  
if  equal  to  6010  or  6011,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
init_wgt_kg      N      keep  
inotrop_support_don      Y   [1.0,  0.0,  nan]   keep  
inr_tx      N      keep  
insulin_dep_don  
if  not  equal  to  1,  set  to  1;  
otherwise,  0   Y   [1.0,  0.0]   keep  
insulin_don      Y   [1.0,  0.0,  nan]   keep  
life_sup_tcr  
  
Y   [0.0,  1.0,  nan]  
remove  due  to  >95  
percent  zero  
life_sup_trr      Y   [0.0,  1.0]   keep  
lityp  
if  equal  to  20,  set  to  1;  else  
0  if  not  null   Y   [1.0,  0.0,  nan]   keep  
macro_fat_li_don  
if  "macro_fat_li_don"  <  30,  
set  to  1;  if  "li_biopsy"=1  
AND  "macro_fat_li_don"  is  
null,  set  to  1;  if  
"macro_fat_li_don"  >=  30,  
set  to  2;  if  "li_biopsy"  is  
null  OR  "li_biopsy"  equals  
0,  set  to  0   Y   [0.0,  1.0,  2.0]   keep  
malig      Y   [0.0,  1.0,  nan]   keep  
malig_tcr      Y   [0.0,  1.0,  nan]   keep  
malig_type  
if  not  in  [4096  to  8192]  and  
not  null,  set  to  0;  
otherwise  1   Y   [nan,  1.0,  0.0]  
remove  due  to  >50  
percent  null  
med_cond_trr      Y   [3.0,  2.0,  1.0]   keep  
meld_diff_reason_cd_1  
if  "meld_diff_reason_cd"  
==  15  or  16,  set  to  1   Y   [0.0,  1.0]  




==8,  set  to  1   Y   [0.0,  1.0]   keep  
meld_peld_lab_score      N      keep  
micro_fat_li_don  
see  "macro_*"  for  
transformations   Y   [0.0,  2.0,  1.0]   keep  
non_hrt_don      Y   [0.0,  1.0,  nan]   keep  
num_prev_tx      N      keep  
on_vent_trr      Y   [0.0,  1.0]   keep  
oth_life_sup_tcr  
  
Y   [0.0,  1.0]  




Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
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ph_don      N      keep  
portal_vein_tcr  
  
Y   [nan,  0.0,  1.0]  
remove  due  to  >95  
percent  zero  
portal_vein_trr      Y   [0.0,  1.0,  nan]   keep  
prev_ab_surg_tcr      Y   [0.0,  1.0,  nan]   keep  
prev_ab_surg_trr      Y   [0.0,  1.0,  nan]   keep  
prev_tx      Y   [0.0,  1.0]   keep  
pri_payment_tcr      Y   [1.0,  0.0,  nan]   keep  
pri_payment_trr      Y   [1.0,  0.0]   keep  
protein_urine      Y   [1.0,  0.0,  nan]   keep  
prvtxdif   filled  null  with  0   N      keep  
pt_diuretics_don      Y   [1.0,  0.0,  nan]   keep  
pt_oth_don      Y   [1.0,  0.0,  nan]   keep  
pt_steroids_don      Y   [1.0,  0.0,  nan]   keep  
pt_t3_don  
  
Y   [0.0,  nan,  1.0]  
remove  due  to  >95  
percent  zero  
pt_t4_don      Y   [1.0,  0.0,  nan]   keep  
recov_out_us  
  
Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
resuscit_dur   filled  null  with  0   N      keep  
sgot_don      N      keep  
sgpt_don      N      keep  
share_ty  
if  3  or  4,  set  to  0;  if  5  or  6,  
set  to  1   Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
tattoos      Y   [1.0,  0.0,  nan]   keep  
tbili_don      N      keep  
tbili_tx      N      keep  
tipss_tcr      Y   [nan,  0.0,  1.0]   keep  
tipss_trr      Y   [0.0,  1.0,  nan]   keep  
vasodil_don      Y   [0.0,  1.0,  nan]   keep  
vdrl_don  
  
Y   [0.0,  1.0,  nan]  




Y   [0.0,  1.0]  
remove  due  to  >95  
percent  zero  
warm_isch_tm_don   filled  null  with  0   N     
remove  due  to  >95  
percent  zero  
wgt_kg_calc      N      keep  
wgt_kg_don_calc      N      keep  
wgt_kg_tcr      N      keep  
work_income_tcr      Y   [nan,  1.0,  0.0]   keep  



















Appendix  B.  Description  of  HCUP  features  for  the  GANN  model  
  
HCUP  Category  ID   HCUP  Description  
1     Incision  and  excision  of  CNS      
3     Laminectomy;  excision  intervertebral  disc      
9     Other  OR  therapeutic  nervous  system  procedures      
10     Thyroidectomy;  partial  or  complete      
12     Other  therapeutic  endocrine  procedures      
33   Other  OR  therapeutic  procedures  on  nose;  mouth  and  pharynx  
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37     Diagnostic  bronchoscopy  and  biopsy  of  bronchus      
42   Other  OR  therapeutic  procedures  on  respiratory  system    
43     Heart  valve  procedures      
48   Insertion;  revision;  replacement;  removal  of  cardiac  pacemaker  or  cardioverter/defibrillator  
61   Other  OR  procedures  on  vessels  other  than  head  and  neck  
67   Other  therapeutic  procedures;  hemic  and  lymphatic  system    
70     Upper  gastrointestinal  endoscopy;  biopsy      
76     Colonoscopy  and  biopsy      
78     Colorectal  resection      
80     Appendectomy      
82   Endoscopic  retrograde  cannulation  of  pancreas  (ERCP)    
84     Cholecystectomy  and  common  duct  exploration      
86     Other  hernia  repair      
99   Other  OR  gastrointestinal  therapeutic  procedures    
104     Nephrectomy;  partial  or  complete      
105     Kidney  transplant      
114     Open  prostatectomy      
124     Hysterectomy;  abdominal  and  vaginal      
126     Abortion  (termination  of  pregnancy)      
146   Treatment;  fracture  or  dislocation  of  hip  and  femur    
152     Arthroplasty  knee      
153     Hip  replacement;  total  and  partial      
158     Spinal  fusion      
160   Other  therapeutic  procedures  on  muscles  and  tendons    
161     Other  OR  therapeutic  procedures  on  bone      
172     Skin  graft      
225     Conversion  of  cardiac  rhythm      
  
